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Delirium is a complex syndrome resulting from compounding effects of acute illness, 
comorbidities, and environment.  It results in adverse outcomes: elevated mortality rates, length 
of stay, readmissions, institutionalization, long-term cognitive changes, and diminished quality 
of life. The rates of iatrogenic delirium are astounding, ranging from 10%-89%. There are no 
curative treatments; thus, primary prevention is the key. The purpose of this literature review is 
to identify and critique the research for accuracy of risk stratification and feasibility in practice.  
Support for interventions that prevent delirium is mounting; however, interventions are resource-
intensive and often not implemented. Researchers have responded to this problem by developing 
risk stratification tools to triage interventions toward those of the highest risk.  There is evidence 
that some of the models' implementation is successful; however, they are not yet widely 
operationalized.  A compilation of seven published models of risk prediction were critiqued and 
compared using the Stetler Model of Evidence-Based Practice as a guiding model.  The 
Newcastle-Ottawa Scale and the Critical Appraisal and the Data Extraction for Systematic 
Reviews of Prediction Modelling Studies (CHARMS checklist) are employed to aid in the 
critical appraisal, evaluation of the study's quality, and aid in data abstraction.  The models show 
the ability to stratify risk, but their effectiveness in practice cannot be studied without directed 
interventions because they risk prediction models are created to aid healthcare staff in making 
clinical decisions.  Therefore, a complete clinical pathway with evidence-based interventions 





at the highest risk.  Recommendations are to implement an automated electronic model 
(automatic calculation using the EMR or a machine learning model) into clinical practice along 
with a delirium prevention care pathway.  Electronic versions of risk scores allow for an 
opportunity to achievement clinical efficiency and show statistical superiority to the other 
models.  Published evidence on the impact of the models is diminutive, their ability to triage 
patients and aid in clinical decision-making should be published in an impact study. 
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According to the Diagnostic and Statistical Manual 5th Edition (DSM-5), delirium is an 
acute cognitive change resulting in an alteration in cerebral functionality of the brain, and its 
severity fluctuates over a short period (American Psychiatric Association [APA], 2013).  
Delirium is a medical emergency indicating the presence of a severe underlying illness resulting 
from a complex compilation of predisposing and precipitating factors that are at the root of its 
onset (Wass, Webster, & Nair, 2018).  Its hallmark signs are disturbances in awareness, 
attention, and perception.  The negative consequences of delirium are far-reaching, impacting the 
patients, families, healthcare staff, hospitals, and healthcare systems. Those with delirium are at a 
higher risk of morbidity, mortality, postoperative complications, prolonged length of stay, 
readmissions, institutionalization, and long-term cognitive changes resulting in a diminished 
quality of life (Douglas et al., 2013; Inouye et al., 1993; Rudolph et al., 2011). 
In acute care settings delirium is the single most common acute disorder affecting aged 
(Carrasco et al., 2014; Health Research and Education Trust [HRET], 2018; & Inouye, 2018).  It 
affects 10% to 20% of all hospitalized adults (over 18 years of age), 14% to 56% of all 
hospitalized patients aged 60 and over, 42% in the general medical settings (Carrasco, Villarroel, 
Andrade, Calderon, & Gonzalez, 2014), and up to 89% of patients admitted to an intensive care 
unit (ICU) (Hayhurst, Pandharipande & Hughes, 2016; HRET, 2018).   
Preventative Interventions 
 Studies show that multifactorial and interdisciplinary interventions result in an overall 
reduction in delirium rates between 30% (Brown et al., 2017) and 53% (Halladay, Sillner, & 





frequent mobilization, promotion of a healthy circadian rhythm, adequate hydration, urinary and 
fecal continence, reorientation to place, time, and situation, therapeutic activities (walking, 
watching tv, listening to music, playing cards, folding towels, or engaging in self-care), use of 
glasses and hearing aids or devices other sensory devices, anesthesia protocols (sedation 
medications to avoid and minimization of sedation levels),  prompt removal of intravenous (IV) 
lines, drains, and restraints, nutritional optimization, and “non-pharmacologic” sleep promotion 
interventions, and pharmacist involvement in decreasing use of medications associated with 
delirium development (Douglas et al., 2013; HRET, 2018; Hospital Elder Life Program [HELP], 
2013; Inouye et al., 1999; National Institute for Health and Care Excellence [NICE], 2010; 
Reston & Schoelles, 2013). The implementation of the interventions requires a clinician to 
recognize and prioritize the prevention of delirium; however, during acute hospitalizations, co-
occurring illnesses often take precedence over delirium risk (Taft, Nelsen, Slager, & Weir, 
2018).  
Guideline and Societal Recommendations for Risk Determination 
There is no known cure for delirium; thus, its management of a delirious patient includes: 
treating the potential causes (precipitating factors), supportive care during recovery, and, when 
necessary, the pharmacological treatment for behavioral symptoms (Michaud et al., 2007). NICE 
published a guideline for delirium recognition and management recommending that all adults at 
risk for delirium should receive tailored interventions to prevent the iatrogenic onset (NICE, 
2014); they list risk factors for delirium but do not suggest a systematic method to determine 
risk.  In response to the need for a systematic method, the HRET proposed that all healthcare 
facilities employ a risk prediction model to identify patients at high risk for the development of 





researchers have been prompted to develop delirium risk prediction models.  Individual 
healthcare systems may have also developed methods to systematically stratify the risk of 
delirium and provide guidance on interventions to implement based on the risk level.  This 
author located two published models that are implemented into clinical practice within two 
healthcare systems (Douglas et al., 2013; Rudolph, Doherty, Kelly, Driver, & Archambault, 
2016).    
Introduction to Delirium Risk Prediction Models 
Despite the high rates of hospital delirium and its adverse effects on a patient, family, and 
healthcare system,  delirium risk prediction models rarely are adopted into practice.  The reasons 
that delirium risk prediction models are not employed include a lack of consensus on the causes 
and pathophysiology, which model to use in which situation, the timing of the assessment, the 
accuracy of the current models in clinical settings, as well as the fact that the guidelines are not 
recommending one model over another (Newman et al., 2015; Wang et al., 2017).   
The first delirium risk prediction model (DRPM) was developed in 1993 by Dr. Inouye 
and colleagues, using a dual prospective cohort study approach, in tandem, to develop and 
validate a risk prediction model (Inouye et al., 1993). This model was never widely adopted into 
practice due to the required acute physiologic and chronic health evaluation scoring that created 
a necessity to draw additional laboratory sample (arterial blood gas).  Some models rely on 
questionnaires administered by health care professionals making integration into clinical practice 
impractical.  Usability in clinical practice is a requirement and includes accuracy of risk 
stratification, ease of use, and timeliness.  In an external validation study by Pendlebury (2016a) 
found that DRPMs must be adapted and simplified to allow for use of routinely collected clinical 





Delirium risk prediction models are developed to allow healthcare providers to target 
high-risk individuals to increase delirium screening assessments and implement targeted delirium 
prevention interventions. Assessing risk is not a new concept to healthcare; however, it is 
becoming more commonly used by healthcare providers to aid in the decision-making process 
when resources are limited, or risk of illness decreases by the implementation of interventions 
appropriate to the clinical question.  Delirium is a complex, iatrogenic syndrome caused by 
numerous predisposing and precipitating factors.  The use of clinical and technologically 
advanced prediction models may allow for triaging of resource-intensive interventions that make 
delirium preventable.  Risk prediction models are most useful in situations such as delirium 
when the outcome is difficult to ascertain due to the immensity of causative factors. 
Background 
Despite early management and treatment of incident delirium it may result in 
considerable consequences for the patients and health care systems.  Increased mortality rates 
during and post hospitalization, an average of eight days prolonged hospital stay, increased risk 
of complications, poor physical recovery and cognitive recovery, increased risk of development 
of dementia, and higher chance of placement in a residential care facility after discharge.  Frailty 
prior to delirium and delays in diagnosis and treatment increase the odds of the occurrence of 
these negative outcomes.   
 Delirium carries an in hospital mortality risk of up to 75% whilst in the hospital and after 
discharge 40% in the first year (Wass et al., 2018).  Delirium has devastating consequences that 
have domino effects for the patient, family, healthcare system, and the population in general. 
According to LaHue et al. (2019), iatrogenic delirium is significantly associated with hospital 





3.44), as well as post-discharge emergency room visits within 30 days of discharge OR: 2.18 
(95% CI: 1.77-2.69). Medicare and Medicaid impose penalties on hospitals with elevated 30-day 
readmission rates; thus, there is a national effort to decrease readmissions rates (LaHue et al., 
2019) thus preventing delirium as part of this effort seems necessary. 
The cost of hospitalization for patients with delirium increase by $16,303 to $64,421 per 
patient (Leslie, Marcantonio, Zhang, Leo-Summers, & Inouye, 2008) resulting in $38 billion to 
$352 billion annually (Douglas et al., 2013).  Less than half of patients fully recover before 
discharge, which incurs additional costs associated with residential care, rehabilitation, and home 
services (Wass et al., 2018).  The 2050 projections on aging note that 88.5 million people will be 
over the age of 65, which is more than double that in the year 2010 (U S Census Bureau, 2010).  
Individuals over 65 are at a higher risk for developing delirium (Douglas et al., 2013) since most 
have multiple predisposing risk factors (male gender, history of cognitive impairment, renal 
disease, liver disease, cancer) and in general, are increasingly vulnerable to insults when multiple 
risk factors are present, or illness is severe (Wass, et al., 2018). Without actions to curb the rates 
of delirium, incidence and consequences will continue to impact patients and the financial 
burden will increase as the elderly population explodes.   
Manifestations of Delirium  
Delirium can affect an individual’s ability to rest, wake, converse, and their awareness of 
surroundings.  It alters a patient’s ability to reasoning resulting in agitation, hallucinations, or 
delusions (Ford, 2016).  The most frequently observed symptom is moderate to severe 
inattention most often detected during a physical exam; elicitation of mild inattention could 
require a formal cognitive test (e.g., digit span, serial sevens, or naming the months in reverse 





three domains: cognitive, executive, and circadian rhythm disturbances (Thurber et al., 2015). 
An individual’s disorientation, memory impairment, and inattention demonstrate cognitive 
effects.  Executive functioning deficits show in a patient's inability to complete a task or thought, 
difficulty with self-regulation of behavior, impaired ability to interact socially, changes in 
speaking ability and speech patterns, and inability to problem solve.  Circadian rhythm 
disturbances result in disturbed sleep-wake cycles, often reversed into insomnia at night with 
fatigue or exhaustion during the daylight hours. 
Three subtypes can categorize delirium; hyperactive, hypoactive, or mixed with both 
hyperactive and hypoactive features. Hyperactive types are the most recognized by healthcare 
providers, as it presents with agitation, emotionally lability, restlessness, sleeplessness, and are 
potentially combative behaviors (Vasilevskis, Pandharipande, Girard, & Ely, 2010). This subtype 
often requires increasing nursing interventions with frequent calls to physicians for medical or 
pharmacological interventions; to manage aggressive, unsafe patient behaviors, and providing 
safety for the staff caring for these patients. Hyperactive delirium is much more involved 
concerning behavioral issues, and these patients are likely to need restraints or chemical sedation 
with medications such as Haloperidol or Lorazepam. 
Hypoactive delirium is the most serious of all subtypes; patients characterized by apathy, 
decreased responsiveness defined as lethargy, unresponsiveness, or coma. These patients are 
typically older than 75 years of age, have many co-morbidities, and present with greater severity 
of illness (Cerejeira & Mukaetova-Ladinska, 2011).  It is the most under-recognized, under-
treated subtype (Vasilevskis, Ely et al., 2010), and is likely to be overlooked and misdiagnosed 
as either depression or fatigue (Cerejeira & Mukaetova-Ladinska, 2011). Evidence indicates a 





recognition and treatment or the immobility associated with this subtype (Vasilevskis et al., 
2010). 
Mixed hyperactive/hypoactive delirium is the subtype in which patients alternate between 
lethargy and hyperactivity. This combination type is unlikely to be the most commonly 
diagnosed because a patient may be misdiagnosed with “sundowners” during periods of 
hyperactivity.  In a study of the prognostic effects of these motor types, Avelino-Silva, Campora, 
Curiati, and Jacob-Filho (2018) state, “hypoactive delirium was the predominant motor subtype 
(53%), followed by mixed delirium (30%) and hyperactive delirium (17%).  Hospital mortality 
rates were respectively 33%, 34%, and 15%” (2018, p. 1).  This study also noted that hypoactive 
delirium had an independent hazard ratio for in-hospital mortality of 2.43 (95%CI =1.64–3.59) 
and mixed delirium resulted in a hazard ratio for in-hospital mortality of 2.31 (95%CI = 1.53–
3.50) (Avelino-Silva et al., 2018, p. 2).  
Understanding the manifestations, subtypes, and the implications of them can aid 
healthcare providers in recognizing its subtle or not so subtle onset.  Recognition of delirium 
improves with the implementation of assessment tools for the onset of delirium in practice 
(Inouye et al., 1993).  These may include tools such as the confusion assessment method (CAM), 
the nursing delirium screening tool (NuDeSC), the delirium observation screening scale (DOSS).   
Pathophysiology    
Due to complexity of physiologic responses to illness and injury, the pathophysiology of 
delirium is poorly understood and rarely researched (MacLullich, Ferguson, Miller, de Rooij, & 
Cunningham, 2008).  MacLullich et al., (2008) proposed two very distinctive classifications of 
etiologies of delirium.  The first are direct brain insults such as trauma, intracranial hemorrhages, 





responses” which result from normal protective functions of the human body in response to 
infections, surgeries, anxiety, and pain (MacLullich et al., 2008).  This stress-diathesis model is 
dominant in literature stating the interaction of predisposing factors and the adequate or 
inadequate stress response (Newman et al., 2015).  Elevated levels of dopamine, impaired 
acetylcholine synthesis and cholinergic synapses, low levels of norepinephrine, 5-
hydroxytryptamine, and y-aminobutyric acid result (Wang, Lyu, Tan, Wang, & Liu, 2017). 
Wang et al. (2017) also report that the insults driven by the external factors (surgery, trauma, and 
infection) active the vascular endothelial cells causing destruction of the blood-brain barrier 
which allows the inflammatory factors to cross into the cerebral tissues, stimulating further 
release of proinflammatory factors and ultimately resulting in neurotoxicity and delirium.  Thus, 
delirium should not be regarded as a psychological issue, instead it should be prevented and 
managed comparably to other diseases (MacLullich et al., 2008; Wang et al., 2017). 
Predisposing and Precipitating Factors  
Recognizing the risk of delirium currently hinges on a clinician’s or nurse’s ability to 
effectively assess patients for  predisposing and precipitating factors and using clinical 
judgement decide if a patient is at risk.  Based on past experience and education of a clinician or 
nurse preventative measures may be implemented. Predisposing risk factors are those that 
describe the vulnerabilities of the individual, which are non-modifiable.  Precipitating factors are 
events that occur with illness or within the healthcare facility, that trigger delirium, which may 
be modifiable. 
According to Mehta et al. (2015), the predisposing factors of significant importance are 
age, history of cognitive impairment (dementia or a history of delirium), and sensory 





benzodiazepines, antipsychotics, oral analgesics, anticholinergic, and sedatives (Mehta et al., 
2015). According to the NICE guideline, the precipitating risk factors are acute infection, 
fracture, emotional or physical stress, surgery or other medical procedures that include 
anesthesia, pain, sedatives, hypnotic medications, anticholinergics, anemia or blood loss, 
dehydration, malnutrition, and electrolyte disturbances (NICE, 2010).  Precipitating factors 
include hospital environments, particularly in the ICU, where frequent disruptions disrupt the 
circadian rhythm. Over one hundred various triggering events are associated with delirium in the 
ICU alone (Vasilevskis, Pandharipande et al., 2010).  Each source and organization vary in their 
lists of these risk factors and each risk prediction model vary in the risk factors used and how 
they are weighted in relative importance.  Tables 1-7 show the models with their risk factors 
including the modified tools by Pendlebury et al. in their model update study (2016a).   
Groves and Huskin (2011) believe that baseline risk is a predictor of delirium likelihood, 
and when a patient has a low baseline risk, despite triggering events, their likelihood of 
becoming delirious is low. However, if vulnerabilities are high and baseline risk is 
High (many or complex comorbidities or severity of illness), then delirium may occur even with 
the most innocuous of insults.   
The consensus is still out as researchers continue to evaluate the relationships between 
the predisposing and precipitating factors and other newer findings such as biochemical, 
environmental, and genetic factors. In all accounts, delirium is a result of the complex 
interactions of both predisposing and precipitating factors (Inouye, 2018; Rudolph et al., 2011) 







Risk Stratification or Prediction Models  
Risk stratification is a technique for systematically categorizing patient risk levels based 
on their health status, predisposing, and precipitating factors. Clinical risk prediction models 
(also known as risk prediction rules, stratification tools or models, risk assessment models, risk 
decision rules, risk scores, risk assessment tools, and indexes) are tools that can determine the 
probability of an event occurring. Healthcare risk prediction or stratification models are essential 
for optimizing of healthcare research, quality improvement, and clinical decision-making 
(Bernard, 2017).  
Assessing risk is not a new concept to healthcare.  It is becoming more common as 
healthcare resources are increasingly limited.  Implementation of risk assessment tools are 
successful in the stratification of other complex medical situations such as the risk of falls 
(Hendrich II), pressure sores (Braden scale), stroke risk in patients with atrial fibrillation 
(CHA₂DS₂-VASc), osteoporosis fracture risk assessment tool (FRAX), and the 10-year heart 
disease risk score (atherosclerotic cardiovascular disease (ASCVD)). The National Institute of 
Health (NIH) and Patient-Centered Outcomes Research initiatives (PCORI) support risk 
prediction tools used to personalize an individuals’ healthcare needs in a personalized dynamic 
manner (Columbia University Mailman School of Public Health, 2019).  Risk stratification 
allows for customized medicine with an emphasis on specific treatments (Agyeman & Ofori-
Asenso, 2015) before any symptoms occur to diminish the risk of illness.  Delirium biomarker 
research is a growing and expanding area of study. Presently there is no biomarker test to 
determine the presence or the risk for delirium. Some of the previously mentioned risk prediction 





for the diagnosis of delirium makes its prediction more complicated than the prediction of other 
conditions. 
  Organizations proposing ways to identify people at risk for delirium include the 
American Nurses Association (acronym) (American Nurses Association [ANA], 2016), the 
HELP (lists of risk factors) (2013), HRET (2018), and the NICE Guidelines (2010) for the 
prevention of delirium (lists of risk factors). These organizations have websites that are integral 
for clinical practice for updates on delirium, including its prevention and management (Table 8). 
 Due to the high mortality, morbidity, cost of care, and impact on patients that develop 
delirium and the health systems that care for them, evaluation of existing DRPMs must be done.  
Researchers continue to create models, but what is lacking are studies on impact, 
implementation, and quality improvement.  Nurses are a key to the assessment and appraisal of 
these models because they are at the bedside caring for the delirious patients.  They aid in the 
implementation of risk assessments and the interventions aimed to prevent this syndrome.  
Nurses additionally are involved in quality improvement projects.  Guidelines state healthcare 
providers need to assess for risk but do not currently recommend a DRPM or any other 
systematic method to stratify risk.    
Purpose 
 The purpose of this integrative literature review is to identify and critique the research on 
delirium risk prediction models for adults admitted to general medical units.  Recommendations 








Clinical Nursing Questions 
 The following clinical nursing questions were developed to guide the literature review. 
Do the validated primary delirium risk prediction model studies: (a) support their claim of 
feasibly in practice, (b) show accuracy and (c) ability to stratify the risk of delirium development 
in the general medical hospital population?   
Method of Inquiry 
 A systematic literature search was completed using the methods outlined by the Winona 
State University Library (n.d.).  It is a five-step approach to provide the seeker with relevant 
articles that will provide information to aid with clinical practice or research.  A five-step method 
provides a simplistic approach for structuring the inquiry and gathering of the literature.  The 
five steps are:  
 Define the project by refining a question and brainstorm related ideas to develop a list of 
key terms 
 Complete a preliminary search 
 Refine the focus and look for quality articles 
 Arrange the ideas in groupings and synthesize the literature 
 Write chapters or sections, placing the literature within each, noting the gaps (Winona 
State University Library, n.d.).    
Literature Review 
 The following sections are a comprehensive review of the literature including a synthesis 
and analysis of the research findings.  Current practices in delirium risk prediction, risk factors 
for each model, statistical significance of each of the eight delirium risk prediction models, their 





discussed.  The studies were included based on their level of evidence, as defined by Ackley, 
Swan, Ladwig, and Tucker (2008).  The studies were appraised by use of the Newcastle Ottawa 
Scale for Quality Assessment which aided in determining the quality of study (Table 9).  The 
levels of evidence description are located in table 10 and a table 11 was created to show the level 
of evidence for each DRPM included in this review.  The Stetler model of research utilization 
(2001) is explained as a model for completion of this literature review.   To highlight and clarify 
the contents of each DRPM and how they were scored (tables 1-7).  
Search Strategy 
To identify the primary studies of DRPMs using clinical data to predict iatrogenic 
delirium an extensive search was completed.  Guided by the Methodological recommendations 
described by the Winona State University Library, the clinical questions guided the search.  
Cumulative index to nursing and allied health literature (CIHNAL), PubMed, PsychINFO, and 
the Cochrane library databases were searched using variations in keywords “delirium” or “acute 
confusional state” with Boolean connections to “rates”, “treatments”, “differential diagnosis”, 
“workup”, “predictors”, “pathophysiology”, “causation”, “cost”, “impact on families”, and/or 
“impact on patients”.  These articles added background knowledge and support to this project 
and are referenced throughout the paper. 
A second exploration was then completed within the same databases to narrow the 
discovery to stratification models which included multiple combinations of the following terms; 
“delirium” or “acute confusional state” or “acute confusion” or “acute brain dysfunction” and 
“risk assessment” or “tools” or “models” or “predict*” or “risk screen*” or “risk stratification” or 





“hospital*”. Exclusions included “alcohol” or “drugs” or “withdrawal” or “ICU” or “fracture” or 
“surgery”.  
Further addition of the subject matter was obtained by a third search focused to answer 
the questions in this review by using ‘One Search’ from the Winona State University Library.  
This search strategy allowed for an expansive search of many databases in less time since it pulls 
together all the library’s resources into one single search. This search provided most of the 
articles included in this review.  The search was limited to peer-reviewed literature; articles, 
dissertations, Journals; the English language, publish dates of 2008-2018 (to ensure the most up 
to date evidence was gathered), adults, older people, geriatrics, aged-medicine, hospitals, and 
medicine with the main subject of delirium.  Titles of articles were reviewed for the keywords 
delirium or acute confusional state (required) and risk assessment, risk tools, risk scores, risk 
models, or risk stratification.  Next the abstracts for the articles of interest were read, further 
narrowing the studies to fit the clinical questions.  After reviewing the abstracts, studies of 
interest were saved for a full review.  When a full-text article was not available online it was 
requested through the Winona State University library.   
A review of full articles revealed further narrowing of the subject was needed to focus on 
general medical admissions because there were many models created for specific areas of the 
hospital or clinical condition such as post-cardiac surgery or orthopedic surgery, or 
ischemic/hemorrhagic stroke focus.  Tools that predicted only prevalent delirium were 
disregarded, keeping the focus on obtaining studies on DRPMs created to determine the risk of 







Search for Recommendations of Statistical Cut-off Points 
Information was sought, to aid in determining ideal AUC cut-off points for the accuracy 
of the risk stratification models.  The literature showed that risk stratification models differ from 
diagnostic models in that the accuracy in diagnosing is not the goal of prediction modeling.  
Instead, they are created to rule out low risk people and limit expended resources by triaging 
people by the level of risk.  An accurate prediction model may limit the resources to 50% of the 
population or less without false negatives.  The most popular statistics of a predictive model is 
the receiver operating characteristic (ROC) curve which is a plot of sensitivity (Se) and 
specificity (Sp) (Cook, 2008).  The ROC or area under the curve (AUC) can also be called a c-
statistic or c index. According to Lee, Bang, and Kim (2016), a model with an AUC of 0.50-0.59 
has poor discrimination power, an AUC of 0.60-0.69 has better than average power to 
discriminate, an AUC of 0.70-0.80 has adequate power of discrimination, and 0.80-0.90 is 
excellent (Lee, Bang, & Kim, 2016).  
The following statistical levels are employed based on the previous recommendations and 
the evidence in the statistical models: a poor performance rating occurs when the AUC, ROC, or 
c-statistic are between 0.50 and 0.59 (as this indicates the model is stratifying risk lightly better 
than a coin toss), moderate performance is between 0.60-0.75, and excellent performance is 
between 0.76-1.0.  Studies of poor performance (≤0.59) were not included in this review as they 
lack statistical significance.  The range of AUC in this review is 0.69-0.85, thus all are proven to 
have moderate or better performance.   
A total of fourteen models were discovered and are presented in the literature review 
table (table 12). During the process of the literature review seven of the studies were not 





validation of a model equates to proof of its applicability in a clinical setting.  Validation of a 
model can be internal (use of the same data set for development and validation of the model), 
temporal (model validation on subsequent patients from the same facility), or external validation 
(model validation in a different facility with a similar population).  Validation of a study proves 
or disproves its clinical credibility, accuracy, generalizability, and preferably shows clinical 
effectiveness (Altman et al., 2009). The unvalidated studies are relevant to the future of delirium 
risk prediction, thus were retained within the literature review tables (Table 12).  The seven 
models critiqued are marked by an asterisks before the first authors name in the literature review 
tables.   
Appraisal and Synthesis of Evidence 
The highest levels of evidence attainable are randomized controlled trials (RCT) or meta-
analysis to answer clinical questions related to the primary prevention of illness. Next in order of 
the hierarchy are prospective studies, cohort studies, case-control studies, and case series 
(Ackley, et al. 2008).  The level V studies include the highest level of evidence for systematic 
reviews of qualitative studies such as a meta-synthesis or an RCT (Ackley et al., 2008).  Three 
studies, that are rated as level V evidence, were found and included in this review which are: 
Models for predicting incident delirium in hospitalized older adults: A systematic review by 
Kalimisetty, S., Wajih, Fay, & Khan, (2017); Systematic review of prediction models for 
delirium in the older adult inpatient by Lindroth, et al., (2018); and Predicting delirium: a 
review of risk-stratification models by Newman, O'Dwyer, & Rosenthal, (2015).  One systematic 
review of delirium risk prediction models focused on understanding the barriers to 
implementation (Newman, O’Dwyer, & Rosenthal, 2015).  The aim of the systematic review by 





current models (Kalimisetty, Wajih, Fay, and Khan, 2017).  A third study aimed to recommend 
the study design for future development of delirium risk prediction models (Lindroth et al., 
2018).  Each of these studies contributed to background knowledge and aided in the 
identification of understanding of DRPMs.  
The seven validated DRPM studies selected for this review were representative of level 
IV studies.  The Kobayashi et al., 2013 and Wong et al, 2018 studies being retrospective cohort 
designs, and the other five are prospective cohort designs.  Five of the studies were completed in 
individual university healthcare centers, one was conducted in two locations of a university 
hospital and validated at a Veterans Administration (VA) medical center.  The final one was 
conducted at 118 VA system hospitals. The least number of participants in the studies was 100 
patients and the most was 27,625 (Wong et al., 2018) with the median participant number at 308. 
All studies lacked randomization and control of variables. The definition of level of evidence can 
again be viewed in Table 11.   
Appraisal and quality assessment cannot be completed with the use of tools created for 
systematic reviews, diagnostic studies, prognostic studies, RTCs, or qualitative studies.   
Discovery of the Newcastle Ottawa scale (NOS) allowed for the evaluation of the prediction 
models study quality.  Critical Appraisal and Data Extraction for Systematic Reviews of 
Prediction Modelling Studies (CHARMS Checklist) provided a method to appraise these primary 
prediction model studies. 
Newcastle-Ottawa Scale (NOS) 
The quality of cohort and case-control studies can be assessed using the Newcastle-
Ottawa Scale (NOS).  It was developed to provide an instrument of ease for evaluating non-





2011). There are not specific quality instruments for evaluation of prediction studies.  Criteria 
included in this tool are selection of the study groups, comparability of the groups; and the 
outcome of interest for the studies and are rated based on a star system. The NOS aided assessing 
the quality of the studies and the creation of a comparative study table to outline relevant data 
from each risk assessment tool (Table 10).  Newman et al. (2015) used the NOS in their 
systematic review noting two of the scale assessments were irrelevant to the DRPM studies.  In 
the selection section it asks if the case definition is adequate, defined by the study being 
independently validated in a similar population, however, significant baseline differences are a 
study strength in prediction model validation, as this shows generalizability of a prediction 
model (Newman et al., 2015).  There are no interventions employed in the research papers thus 
follow up of patients was not needed, therefore, ‘adequate follow up after an intervention was 
employed’ was also removed from the scoring.  A quality rating of 7 was used instead of 9 for 
scoring.   
CHARMS Checklist   
The CHARMS checklist is designed to aid in reviewing and appraising of all types of 
primary prediction modelling studies (Moons et al., 2014). Additionally, it aids in data extraction 
of the individual studies in eleven domains: source of data (type of study), participants, predicted 
outcomes, candidate predictors, sample size, missing data, development, performance, 
evaluation, results, and interpretation/discussion. (Moons et al., 2014). Prior to this checklist 
there were no systematic methods for evaluating primary prediction modeling studies (Moon et 
al., 2014). Though this tool is intended for primary studies it was additionally used here to aid in 
data extraction from the systematic reviews noted in this paper.  The systemic reviews included 





within this literature review. Understanding the currently published research is an important 
aspect of clarifying the gaps in research.  The CHARMS checklist allowed a format to display 
the relevant study data (Table 13) found in the three systematic reviews since they are lightly 
discussed in this paper and highly relevant to future research or implementation of DRPMs. 
Themes 
It is evident in the literature that delirium results in detrimental effects for the healthcare 
systems, patients, and families.  The rates and healthcare costs of delirium are unchanging with 
current practices in delirium risk prediction, prevention, and management and are expected to 
increase as the percentage of elderly population increases.  The literature uncovers a lack of 
systematic methods to determine risk in current practice.  The studies all report similar statistics 
and report their ability to stratify risk based on statistics.  Lastly, model ease of use in clinical 
practice is a past barrier that must be addressed in the development of DRPMs.  
The Impact on Health Systems, Patients, Families and Nursing Staff  
The impact of delirium is far reaching for healthcare systems as the financial burden and 
resource utilization creates a strain on our health care systems. Implementation of delirium care 
pathways in acute care can decrease rates of onset, severity, and length of delirium in 
hospitalized patients (Inouye et al., 1999) and reduce overall costs of hospitalization (Brown et 
al., 2018). Increased length of hospitalization can lead to adverse outcomes, particularly in the 
elderly due to increased frailty (Vincent, Neale, & Woloshynowych, 2001). Falls, decubitus 
ulcers, feeding problems, urinary incontinence, urinary infections, and fractures are reported in 
literature to be a result of extended hospitalization (Groves & Huskin, 2011). The length of stay 
is a way organizational performance is measured.  Preventing the onset of delirium or lessening 





healthcare providers to affect the length of stay and improve organizational performance 
measures. 
Whitehorne, Gaudine, and Meadus (2015) reported that patients post-ICU delirium had 
poor or no recall of events, difficulty making connections and communicating simple needs, 
struggled with distinguishing reality from hallucinations and paranoia, and recalled feelings of 
being in imminent danger.  Delirium creates a state of personal distress.  The hallucinations are 
detrimental to the long-term mental health of a patient who believes they are real while recalling 
the experience (Whitehorne, et al. 2015). The following is a recollection of a recurrent 
hallucination experienced by a patient who recovered from delirium.  It shows that patients 
experience long-term psychological trauma.   
The one that was most upsetting was the monkeys … up in the lights...You could hear 
them jumping up and down, and they were bawling like they were trying to get at me. 
They were on all the lights, not just at the one that was at my bed but all around the 
room...They were savages...I didn't know…if they wanted to get out or get at me.… I'm 
still afraid to look up at the lights...And I always…whisper because I'm afraid they'll hear 
me.  (Whitehorne et al., 2015, p. 477) 
The cognitive changes resulting from delirium may necessitate 24-hour caregivers, 
causing financial strain or long-term care center placement for safety. The consequences of 
cognition impairment are a loss of independence, acceleration toward dementia, and early 
mortality. The effects of delirium can persist for months in 20% of the cases (MacLullich & Hall, 
2011).  
Caregivers offer support and provide care to family members with persistent delirium 





family members that are their caregivers, creating a burden of care (Abrantes & Racine, 2019). 
Three types of burdens laid on family members: symptom burden, emotional burden, and 
situational burden (Abrantes & Racine, 2019).  Symptom burden is the experience and 
observation of the disorientation and personality changes that make the patient virtually 
unrecognizable.  Greater than 70% of spouses reported stress related to the toll of caregiving and 
close family (Page & Ely, 2017).  Friends and families worry that the cognitive changes are 
permanent (Page & Ely, 2017). Situational burden occurs as the result of feeling loss of control, 
safety concerns, lack of support, and the unpredictability of the course of delirium (Abrantes & 
Racine, 2019). 
Page and Ely (2017) state nursing staff caring for delirious patients experience frustration 
and stress while trying to care for and comfort them (p.107).  Nursing challenges occur whilst 
providing basic care to ensuring safety, protecting patients from causing harm to surgical sites, 
removing IV lines, Foley catheters, arterial and central venous lines; all while providing nursing 
care for the presenting illness.   
Current practices for Risk Determination 
In the current state of delirium management, healthcare providers individually use 
clinical judgment and their learned knowledge of delirium to assess a patient for delirium risk. A 
clinician must recognize and be cognizant of the predisposing and precipitating factors that 
trigger incident delirium. Delirium prevention bundles, clinical practice guidelines, 
organizational guidelines, and hospital-specific  
pathways list various risk factors, however, do not recommend specific stratification tools. 
In ICU’s across the United States, standard practice is to implement the ‘ABCDEF 





Medicine (2018). This “bundle” provides nurses with interventions to reduce delirium, provide 
adequate pain management, and reduce the long-term consequences of delirium in adult 
intensive care unit (ICU) patients (Society for Critical Care Medicine [SCCM], 2018). This 
bundle called the Assess, prevent, and manage pain; Both spontaneous awakening and breathing 
trials; Choice of analgesia and Sedation; Delirium assess, prevent, and manage; Early mobility 
and exercise; Family engagement /empowerment, is implemented for every ICU patient, since all 
ICU patients are considered at high risk for delirium and poor clinical outcomes. A recent study 
by Pun et al. (2019) found that over 15,000 patients receiving the ABCDEF bundle interventions 
had decreased rates of incident delirium, restraint use, intubation length, mortality rate, 
readmission to ICU, and were more likely to discharge to home rather than long-term care 
centers.  This study also noted a decrease in the length of mechanical ventilation, coma, and 
delirium (Pun et al., 2019). Due to the positive effects of the ABCDEF bundle, the SCCM 
recommends all ICU’s to employ this delirium bundle as the rates of delirium can be diminished 
and healthcare quality can be improved (SCCM, 2018). 
Bundles of care for the inpatient units are less frequently employed; thus, patients 
continue to develop delirium at uncontrolled rates on medical units. The Hospital Elder Life 
Program is a research-based comprehensive program for the prevention of delirium in 
hospitalized older adults (HELP, 2019). This program utilizes hundreds of volunteers to assist 
with activities to keep patients alert and awake during daytime hours, meet hydration and 
nutrition needs (feedings), and encourage movement. According to their website, there are 200 
sites (in 32 states and 11 countries) that have employed this program, including Methodist 
Hospital in Minnesota (HELP, 2019). The study by Zaubler et al. (2013) showed that 





delirium, a two day decrease in the length of stay, and a nine-month cost-savings of $841,000.00 
(Zaubler et al., 2013). Additionally, the HELP website also notes that HELP implementation 
studies have resulted in the prevention of cognitive decline, reduced nursing home placement, 
decreased hospital rates of falls, and a reduction in the use of 1:1 sitters (HELP, 2019). 
 Brown et al. (2018) published an impact and implementation study on the AWOL tool in 
practice as part of a multicomponent prevention pathway (AWOL, CAM, and interventions to 
those triaged as a score of ≥ 2).  This study reported a decrease in length of stay of >2 days, 
decreased 30 day re-admission rates from 11% to 5.45%, less restraint and 1:1 sitter use (Brown 
et al., 2018).  There were no reductions in hospital days which were explained by stating that the 
interventions employed were studied in general medicine populations, but the impact study had a 
majority of neurological patients and increased recognition and sensitivity to delirium in general 
may elevate diagnosis of delirium.   
Supporting Evidence for Risk Stratification 
Delirium risk determination and prevention strategies are recommended by organizations 
such as NICE Delirium Guideline, the Iatrogenic Delirium Change Package, Delirium: 
Guidelines for General Hospitals, and the Delirium Prevention Strategies by the ANA (2016). 
Each of these documents list the risk factors but not one of the guidelines describe a method to 
adopt for a consistent, system-wide assessment for risk stratification. Clinical practice guidelines 
were reviewed in an attempt to clarify current practice to determine risk and not to review them 
for the purpose of interventions and application to practice, thus they are not critically appraised 
in this literature review. 
The iatrogenic delirium change package was the only guideline to state the following 





 Adapt and adopt a risk assessment tool that examines the following risk factors: 
age, dementia, metabolic imbalance, hypertension, alcohol abuse, severity of 
illness, coma and benzodiazepine administration.  
 Assess the risk for delirium upon hospital admission, transfer within hospital or 
change in patient behavior.  
 Develop prompts to promote the completion of the assessment and include the 
assessment on the admission checklist or in charge nurse rounds (HRET, 2018, p. 
6).  
The American Nurses Association (2016) developed a delirium prevention pathway that 
again states that the recognition of risk is the first step. The pneumonic, MIND SPACES, was 
created to aid healthcare providers to recall the predisposing and precipitating factors. Since this 
technique has not been researched or reported in quality improvement studies, it is difficult to 
determine its effectiveness and assumes staff will recall this acronym. As with previous 
guidelines, the ANA did not create this to be a DRPM, but simply a list of risk factors (ANA, 
2016).   Of note, NICE Guidelines state that all adults whom are at risk for delirium and are 
newly admitted to a hospital or long-term care center should receive a range of tailored 
interventions to prevent delirium (NICE, 2010). 
As evidenced by the steady rates of delirium, the current methods of determining risk for 
delirium are failing the at-risk population.  Healthcare providers fail to recognize both the risk of 
delirium and the onset of delirium all together; thus, clinical judgment alone is not enough to 
change the trajectory and prevent delirium from occurring.  Implementing DRPM’s into practice 
may improve recognition of delirium and diagnosis rates of delirium, as well as prevent its onset 





from occurring (Douglas et al., 2013). Implementation of preventative interventions in practice 
are recommended by the SCCM, ANA (2016), and clinical practice guidelines. Within the next 
sections, the reader will be introduced to the statistics of risk prediction models to obtain a 
baseline understanding of the accuracy of the DRPMs presented in this review. 
Delirium Risk Prediction Models: The Statistics  
In the following paragraphs studies are compared based on their ability to accurately 
predict and stratify the risk of developing incident delirium.  Each study followed a similar path 
for determining the independent predictive factors. They collected baseline characteristics such 
as demographics, living situation, age, sex, comorbidities, cognitive status, and varied in their 
collection of baseline lab values, medications, vital signs, infection, fracture, and admitting 
diagnosis.  One study included dependency with activities of daily living, presence of urinary 
catheters, IV therapy, oxygen, and pressure sores as characteristics (Martinez et al., 2012).  
A total of seven models were selected for appraisal and comparison for this literature 
review.  They are:   
 ‘Clinical Prediction Rule for Delirium’ by Martinez et al. (2012);  
 Chi-Square Automatic Interaction Detector (CHAID) decision tree model by 
Kobayashi et al. (2013);  
 ‘AWOL’ by Douglas et al. (2013) 
 Delirium Prediction Score (DPS) by Carrasco et al. (2014);  
 ‘E-NICE’ by Rudolph et al. (2016)  
 ‘Delirium Susceptibility Score (DSS)’ by Pendlebury et al., (2016a);  






An additional study updating four of the models in preparation for a new model (DSS) 
was included in the review: 
 Delirium risk stratification in consecutive unselected admissions to acute 
medicine: validation of externally derived risk scores (Pendlebury et al. (2016a) 
An implementation study completed by Brown et al. offers significant clinical support of 
DRPM implementation into practice: 
 Predicting inpatient delirium: The AWOL delirium risk-stratification score in          
 clinical practice (Brown et al., 2017) 
      Another study included shows evidence in favor of DRPMs in practice is an implementation 
and clinical impact study: 
 Evaluation of a multicomponent pathway to address inpatient delirium on a 
neurosciences ward (Brown et al., 2018) 
For statistical comparison, all seven prediction model studies and the additional three 
supporting studies reported the area under the curve (AUC) statistics as either the area under the 
receiver operating curve (AUROC), AUC, receiver operating curve (ROC), or the concordance 
statistic (c-statistic or c-Index), thus enabling ease of comparison of discrimination.  A model's 
ability to differentiate between those at high risk and those at low risk is its ability to 
discriminate.  Attention should focus on the sensitivity (true positive rate) more than the 
specificity (true negative rate) when choosing tools to predict delirium risk, allowing for 
stratification by including nearly all that developed delirium (Ho, et al., 2019).  The calibration 
of a model determines if the observed risk matches the predicted risk.  Thus, both calibration and 





prediction models; in these models, calibration results as percentages of positive delirium 
patients per risk level (Table 14).   
The models included in this review are those with moderate to good performance range 
like the AWOL risk score developed by Douglas et al. (2013), which reported an AUC of 0.69 in 
the development study, an AUC of 0.73 in the Pendlebury et al. (2016a) update study, and a 
AUC 0.69 in the comparison study by Brown et al. (2017).  Wong et al. (2018) compared the 
AWOL to newly developed electronic DRPM’s. The AWOL models’ discrimination in the 
external validation cohort resulted in an AUC of 0.678 (showing consistency of the model from 
the original development by Douglas et al., 2013). The logistic regression model developed in 
the Kobayashi et al. 2013 study, was among the best performing of the non-electronic group with 
an AUC of 0.79 in the validation cohort.  Interestingly, the validation cohort performed slightly 
better than the development cohort that had an AUC of 0.78, which can suggest over-fitting of 
the model.  Over-fitting of the model to the sample population is possible when the AUC in a 
validation study is higher than that in the development cohort and means that the model was 
fitted to the validation population and thus may not be generalizable to other populations without 
further external validation studies to prove otherwise.   
The future of risk prediction lies in machine learning or neural networking.  The advent 
of the electronic medical record presents an interesting possibility for future prediction modeling 
as they record relevant patient information.   These predictors are weighted (weights are 
commonly derived by logistic regression), which results in a score, then these scores are fitted 
into the models’ predetermined levels.  These models rely on accurate chart documentation, 
including complete and accurate history, diagnostic coding, and results of labs. The electronic 





Rudolph et al. (2011) (e-NICE), and the Wong et al. (2018) (machine learning models; “gradient 
boosting machine (GBM)”, “Penalized logistic regression (PLR)” and “random forest” analysis 
(RF)).  The CHAID had the lowest AUC in the validation cohort at 0.82.  Wong’s RF model had 
an AUC of 0.848, the PLR model is 0.854, and the GBM had an AUC at 0.855. The e-NICE 
model was the highest with an AUC of  0.91 (Brown et al., 2017).   
The non-electronic high performer was Martinez et al. (2012), as the validation cohort 
had an AUC of 0.85, keeping in mind that the development cohorts AUC was 0.77 (considering 
overfitting of the model). The authors noted that that additional work to rule out overfitting is not 
needed as it was of no clinical significance.  The validation study had the same patient 
population and setting with a higher incidence in delirium diagnosis (25% vs. 13%) in the 
development cohort and more dependence on others for assistance with ADL’s. A second non-
electronic model with high discrimination was found in the external validation study that 
Pendlebury et al. (2016a) completed, the model created by Isfandiaty found an AUC of 0.83. 
(validation of this developed tool was not completed; therefore, it is not included in the literature 
review).  Statistical comparisons of the seven studies, along with the model update study by 
Pendlebury et al. (2016a) are entered into a table 14. 
The capacity to stratify risk. The ability of a model to stratify risk is evaluated based on 
the accuracy of the proportion of each population’s allocation into risk levels (Steyerberg, et al. 
2010).  The best models will effectively place subjects at both extremes of the risk distribution, 
thus enabling clear implications for future actions.  Perfect models assign into only the highest 
risk and the lowest risk levels with no in-between, leaving no room for error of missing an event.  
Cook notes that there are no perfectly calibrated models (2008).  A useless model will assign the 





0.50 (Steyerburg et al., 2010).  A model’s calibration, or capacity to stratify the population into 
risk categories, and the accuracy of the classifications are the critical attributes of a model.   
For comparative purposes, healthcare providers can review the true positives and 
negatives, false positives and negatives, as well as percentages of definite diagnosis, and ensure 
that the rates of delirium are increasing with the higher risk categories.  Martinez et al. (2012), 
Douglas et al.  (2013), Kobayashi et al. (2013), and Rudolph et al. (2016) models compare each 
risk level based on percentages of those with and without delirium in each level.  Martinez et al. 
(2012) has the highest percentage of patients at their highest level; 64% of those with delirium 
are included in this level.  Of note 44.4% of those with a score of ≥1 (highest stratification score) 
developed delirium, and only 7% of those classified as low risk developed delirium.  The 
Martinez et al. model also has the potential to limit necessary interventions to 53% of the total 
population, making rationing of interventions possible, which is the goal of stratification of risk.   
The Douglas et al., (2013), AWOL score sets a score of  ≥ 2  as high risks.  Eleven 
patients in this cohort are positive for delirium or 13.5% of the 165 patients included, of 
importance is that only 3.5% of all those said to be low risk developed delirium showing good 
calibration. The score of  ≥2 captured 11 positives out of fourteen, which results in 79% 
accurately stratified. At this score, interventions would be limited to only 49% of the population 
allowing for an improved resource utilization.  Interestingly, at zero factors one still developed 
delirium and a score of four, none developed delirium.  The sample size of this study was just 
165 patients, which could account for less reliable results.  The Pendlebury et al. study (2016a) 
updated the AWOL model and improved the capacity to stratify risk as evidenced by an 
improved AUC of 0.78 and the Se still increases with each risk level and PPV increasing to 0.70 





 Comparatively, the CHAID decision-tree model, is unique in its application and 
statistical reasoning (Kobyashi, 2013).  It can be used both electronically and on paper as an 
algorithm as demonstrated in Table 4.   There is no cutoff score for risk stratification; instead, it 
is a model that identifies the presence of risk factors and follows a decision-tree to determine risk 
levels.  Those noted to be moderate to highest risk levels are of two categories. The first split is 
those with a known history of delirium.  The study notes that those over age 75 have an 
increased risk and account for 7.9% of the incidence of delirium. This decision-tree does not give 
the compounding risk of a patient whose age is ≥ 75 with malignancy and impaired ADL’s thus, 
the reader presumes very high risk.   
In the Rudolph et al. (2016) validation study (e-NICE), the rates of incident delirium 
increase significantly with increasing risk scores. With the addition of the Modified Richmond 
Agitation Sedation Scale (mRASS), there is an increased ability to stratify the high-risk category.   
In this model, risk levels that were high and very high-risk combine capturing 27 positive 
patients out of 246 total patients, but misses 16 of those delirious or 6.5%, which is unacceptably 
elevated since the goal is to prevent the highest number of those who developed incident 
delirium.  The e-NICE model performs better in the developmental retrospective cohort than the 
prospective cohort as the development cohort has lower percentages of missed delirium in those 
categorized ≤5.  For scores ≥6, the true positive rate (TPR) is 63% (27/43), and the false positive 
rate (FPR) is 33% (60/182), showing that more patients were correctly classified as a high risk 
rather than falsely classified.   Eighty-seven patients were high risk out of 246, therefore only 
35% (81 patients) of the total population would require interventional pathways.   
The researchers in the consolidated e-NICE, Rudolph et al. (2016) model, offered 





mRASS would increase the number to treat to 108 with 40.7% of them delirium positive.  If the 
score decreased to ≥3, it would capture 33 more positively delirious patients and increasing 
treatment to 52.4% of the total population, still allowing for triaging, thus the allocation of 
resources.   
The Pendlebury et al. (2016a), Pendlebury et al. (2016b) and Carrasco et al. (2014) 
studies display the Se, Sp, PPV, and NPV of each level of prediction.  In the Pendlebury (2016a) 
study, the models compared and updated were Inouye et al., 1999, Martinez et al., 2012, Rudolph 
et al., 2011, and Douglas et al., 2013. The updated tools contained very similar predictors while 
their Se, Sp, PPV, and NPV also resulted similarly.  This study reported that no model 
statistically performs significantly better than another.  As a result of this update study, 
researchers developed a Delirium Screening Scale (DSS) model which improved on the Se, Sp, 
PPV, and NPV as evidenced by an AUC of 0.81 (Pendlebury et al., 2016b).  This is one of the 
few studies that reports odds ratio which for a score of 5-7 vs a score of  ≤2 is 25 with a relative 
risk of 13 proving that the higher score is related to greater risk.  The odds ratios for all the 
scores for this model and other models are noted in Table 14.   
The Carrasco et al. (2014) study is unique with the use of a mathematical equation 
formulated out of lab values (BUN/Creatinine ratio) and the Barthel Index.  Any score > -240 
predicts high risk, and interestingly, 99% of those that are low risk (<-240) did not develop 
delirium.  This tool was exceptional at stratifying those at high risk for delirium; however, the 
Barthel Index adds complexity to an assessment, and it may have less merit clinically. 
The Wong et al. (2018) study is unique as it compares and externally validates the 
AWOL tool while it integrates hundreds of predictors (796 variables and the GBM contains 345 





AUCs.  All of their models use chart abstraction methods to calculate and stratify the risk score.  
The strength of this model is the ability to adjust the sensitivity and specificity to the desired 
level of the individual facilities.  The statistical power this tool has allows for improved 
accuracy, which results in a narrowed number of patients targeted for interventions as evidenced 
by the number needed to screen of 4.8.   
The DRPM’s must have the ability to stratify risk levels appropriately, allowing for 
allocation of the preventative interventions for a targeted population.  Outcomes of clinical 
application studies, such as Browns’ (2017), are among the best clinical evidence to support or 
negate the use of a model in clinical practice (Brown et al., 2017).  The statistics are represented 
in Table 14 which report the values as they relate to the predictive power of each stratified risk 
level, from which critical appraising and evaluations for clinical application can consider all 
scenarios.  
Model Feasibility in Practice  
To understand model feasibility in practice it is necessary to investigate the barriers to 
adopting DRPMs in current practice.  Three studies were discovered that reported the barriers to 
clinical practice through the perception of a physician or a nurse.  The Newman et al (2015) and 
Kappen et al. (2016) studies reported on physician perceptions and the Brown et al. (2015) study 
reported on the nurses perceptions.  The systematic review by Newman et al. (2015) reported the 
barriers to clinical implementation of DRPMs.  One obstacle is that health care healthcare 
providers perceive their use as complicated and time-consuming (Newman et al., 2015).  Some 
of the variables included in the models were not available or tested upon admission (Newman et 
al., 2015).  The overall theme in this review of studies was that the complexity of the predictors 





Since the study by Newman et al. (2015), there was a study reporting the implementation 
and impact of a DRPM on a medical ward as part of a nurse-driven delirium care pathway by 
Brown et al. (2015).  Nurses are responsible for completing the AWOL tool; unfortunately, the 
reported completion rate was only 48.6%.  The researchers, Brown et al., then followed up with 
nursing in regard to what were the barriers to completion.  The obstacles published are: (a) Lack 
of nurses time to complete (b) perceived lack of training, (c) the documentation was not required, 
(d) nurses were frequently disrupted in their workflow, and (e) nurses stated that it wasn't a unit 
priority (2017).  The research team addressed all barriers and found an improved completion rate 
of 90%; thus, they suggest investing in more resources before and during implementation, 
supporting the use of the model (Brown et al., 2015).  Additionally, Brown et al. found that the 
AWOL score could not be completed in patients who had a language barrier (somnolence, 
aphasia, or a non-English primary foreign language).  They note modifications of this tool 
include translation and alternative assessments for cognition in aphasic patients similar to those 
used in intubated patients (Brown et al., 2017).   
Kappen et al. (2016) studied physician perceived barriers to implementing a risk 
prediction model on postoperative nausea and vomiting.  They noted that physicians state the 
outcome is not the main area of attention, their decision-making process is intuitive rather than 
analytical, knowledge of the risk level should be accompanied by corresponding management 
recommendations (knowledge of risk itself is insufficient), and prediction models do not weight 
benefits and harm of the interventions (Kappen et al., 2016).    
To combat these barriers actionable interventions based on risk need to accompany the 
risk model, risk stratification should be automated into the workflow, reasoning explained with 





direct practice will result in improved perception (Kappen et al., 2016).  Knowledge of the 
barriers to use of risk prediction models will aid in creation of structured implementation of them 
in practice. 
There are two DRPMs currently utilized in practice, the AWOL model and e-NICE 
(Rudolph et al., 2016; Douglas et al., 2013).  Bedside RNs complete the AWOL upon patient 
admission and the e-NICE is a completely automated tool alerting healthcare providers to the 
risk level.  The e-NICE electronic abstraction tool provides the Veterans Administration (VA) 
hospital system healthcare providers with a daily list of those inpatients at the highest risk.  Of 
note, the AWOL study is researched in three additional reviews: Brown et al., 2017; Pendlebury 
et al., 2016a; and Wong et al., 2018.  The Brown et al. (2017) study they found the AWOL has 
AUC of 0.73 with 4% of the delirious with a score of 0, 6% with a score of 1, 42% with a score 
of 2, and 57% with a score of 3, and none of the incident delirious patients in this cohort had a 
score of 4.  In the Brown et al. (2017) study, they had an AUC of 0.73, the Pendlebury et al. 
(2016a) study resulted in an AUC of 0.78, and the Wong et al. (2018)  found an AUC 0.678.  
The AWOL tool is available on the software application MdCalc (2017), improving its ease of 
use and availability. 
Barriers created by DRPMs prevent the implementation of these systematic methods to 
predict risk in clinical practice.  The more recent DRPMs researchers have answered this with 
risk prediction models that include predictors that are available upon admission.  Models that 
include complex assessments such as the Barthel index or a mRASS are being rejected by 
healthcare providers because they are too time consuming.  Automated risk scores may be the 
answer to the feasibility concerns as they allow a hands off assessment of risk, with predictors 





2018 and Rudolph et al., 2016.  Unfortunately, some healthcare systems are not ready for 
automation.  The AWOL (Douglas et al., 2013) contains predictors to be assessed upon 
admission and an online calculator for scoring on MdCalc.  The DSS model (Pendlebury et al., 
2016b) contains predictors that are readily available upon admission.   
The ideal time to assess for delirium risk is upon admission before delirium develops, and 
at a point that preventative interventions implemented are effective (Douglas et al., 2013; Wong 
et al., 2018).  Thus, the ideal model contains predictors commonly obtained on admission or 
readily available in the chart.  The following studies by Douglas et al. (2013); Martinez et al. 
(2012); Pendlebury et al. (2016b); Rudolph et al. (2016) & Wong et al. (2018) included 
predictors that were available upon admission or shortly thereafter, increasing their clinical 
merit.    
The first DRPM included four predictors: the Acute Physiology and Chronic Health 
Evaluation II score (APACHE II), history of cognitive impairment, presence of dehydration 
(BUN/Creatinine), and visual impairment (glasses or blindness) (Inouye et al., 1993).  The 
APACHE II score created complexity by requiring assessments including the Glasgow coma 
scale score (GCS), temperature, Mean Arterial Pressure (MAP), heart rate, respiratory rate, 
FIO2, and the lab values of a PaO2, arterial pH, bicarbonate, sodium, potassium, creatinine, and 
hematocrit (Knaus et al., 1985).  Not all of these tests (arterial blood gas to assess the PaO2, pH, 
and bicarbonate levels) or assessments (Glasgow coma scale) are clinically necessary for 
evaluation of all patients admitted resulting in ordering additional tests to complete the risk 
model.  Extra testing increases healthcare costs, pain, and exposure to the risk of procedures such 
as the arterial blood gas (ABGs) collection.  This model is not adopted in clinical practice due to 





(Douglas et al., 2013; Pendlebury et al., 2016a).  Refer to Tables 1-7 for a simplified way to 
discover the predictors included in each of the seven models.   
As evidenced by Inouye and colleagues' model of 1993, DRPM must contain predictors 
that are likely to be obtained upon admission (laboratory studies or assessments), carry a low 
burden to collect, and quickly calculate the risk levels.  As Rudolph et al. (2011), Pendlebury et 
al. (2016a), and Wong et al. (2018) point out, tools for future practice need to be simple, 
credible, and externally validated.  Additional specialized assessments such as the MoCA 
(Montreal Cognitive Assessment), MMSE (Mini-Mental Status Exam), APACHE II Score 
(Acute Physiology And Chronic Health Evaluation), Barthel Index, or the Charlson Comorbidity 
Index are too cumbersome to include in a bedside risk prediction model (Newman et al., 2015).   
These assessments require additional training for staff and are of less clinical use due to low 
completion rates (Carrasco et al., 2014).   In the updated Pendlebury (2016a) study, 
modifications to the models for ease of use without impacting the accuracy of prediction.  
Perhaps the most straightforward yet technically complex score is the machine learning 
models in the study of the Wong et al. (2018).  All tools reported in this study have published 
superior statistics in comparison to the non-machine learning tools.  This study resulted in the 
Gradient Boosting Machine (GBM) model, which contains 345 predictors electronically 
collected from the chart allowing for the automated extraction of the health data and alerting the 
clinical teams to elevated risk scores.  The authors compared the model to the AWOL and noted 
that the GBM could target those at the highest risk with improved accuracy, thus limiting 
focused interventions to less than half that of the AWOL (Wong et al., 2018). 
The Wong et al. (2018) electronic models are very complex computerized programs and 





calculations of risk without additional assessments by healthcare providers (Wong et al., 2018). 
In the current healthcare environment, it is desirable because it frees up healthcare providers 
time.  
Summary of Research Findings 
The statistical evidence confirms validated delirium risk prediction models have the 
ability to stratify the risk for delirium.  Each of the models report both discrimination and 
calibration as the AUC, sensitivity and specificity, or percentages of positive outcomes in 
relation to risk scores.  A model that can discriminate has the ability to categorize high versus 
low risk.  A well calibrated model effectively determines higher risk levels in correlation with 
increasing true positive rates.  However, a model cannot be implemented simply based on its 
statistics.  Models for clinical practice must also be feasible in practice (easy to use, consume 
very little clinical time to preform), utilized at the appropriate time, and must stratify the risk 
accurately (minimal false negative cases).   
The systematic review by Newman et al. (2015) studied the barriers to implementation 
were that healthcare providers perceived too much time to assess and score models, models are 
complex and not understood, limited supporting evidence of the models clinical impact, and 
there were not recommendations for clinical decision-making based on the level or risk.  
Interestingly the automated computerized models (e-NICE and GBM) report both the highest 
ability to stratify risk with both a high Se and Sp, limiting the interventions to a narrow group of 
patients with minimal miss classification of positive cases of delirium.  Because these model 
results are computer generated, they require no further assessments for providers, making them a 





As for as implementation and impact studies, Newman et al. (2015) was unable to 
discover any published studies and noted they did not find evidence that any models were 
employed in practice prior to the studies publication.  New evidence has emerged reporting 
successful implementation of a delirium prevention care pathway using the AWOL model to 
triage the use of interventions to those assigned a risk score of ≥ 2 (Brown et al., 2015; Brown et 
al., 2017).  This evidence shows that use of a DRPM, as part of a delirium prevention bundle, 
can diminish the severity of delirium mitigating some secondary effects.  It also relays a benefit 
of decrease in length of stay of > 2 days (Brown et al., 2017).  The Brown et al. (2017) study is 
the only impact study discovered during the literature search employing the use of a DRPM as 
part of a multicomponent interventional pathway.  This evidence suggests that DRPMs should 
not be implemented alone, but within a care pathway to impact the consequences of delirium.  
DRPMs allow resources to be allocated to those at greatest risk, decreasing use of limited 
resources such as volunteers, physical and occupational therapy, psychology consults, pharmacy 
consults, or involvement of a geriatrician.  The preventative strategies implemented must 
proceed the triggering factor of modifiable precipitating factors to be effective (Brown et al., 
2017).    
What methods are recommended for clinicians to triage preventative interventions for 
those at highest risk for development of delirium?  Clinical practice guidelines and associations 
such as the ANA, SCCM, and HRET support determination of risk as the first step to 
multicomponent prevention pathways.  Each of these organizations or guidelines discuss the risk 
factors for delirium and provide a long list or a pneumonic of them to be recalled during clinical 
practice.  The ANA and SCCM do not discuss DRPM or suggest any systematic methods for 





delirium risk prediction model. Interestingly this published “package of change” is the most 
recently published recommendations for iatrogenic delirium management.  
Gaps in Literature 
Clinical decision-making is aided by risk prediction models in many settings of medical 
care.  There are no studies reporting or focusing on what effects DRPMs have on the clinical 
decision-making of clinicians.  The recommended delirium preventative care pathways, unlike 
risk stratification for stroke (CHA₂DS₂-VASc, which directs clinicians on use of anti-coagulation 
therapy based on calculated risk score (January et al., 2014), do not provide stepped levels of 
interventions based on calculated scores.   Studies additionally stated that determining patients at 
risk and alerting providers to the elevated risk may improve recognition and diagnosis of 
delirium risk (Douglas et al., 2013; Rudolph et al., 2016).  There is no clear evidence to support 
the claim that DRPMs enhance diagnosis of delirium by clinicians.  Reporting evidence to 
address these gaps may improve support of DRPMs use in clinical practice.   
Some models being developed are aimed at a very narrow population of focus, such as 
models for ICU, surgical patients, or patients with fractures rather than a broader, generalized 
population like the general acute care hospital admission population (Lindroth et al., 2018).  
Lindroth et al. (2018), with a focus on older, found 23 prediction models, 11 medical, 3 
medical/surgical, and 9 for various surgical procedures.  Another study reported finding 37 
DRPMs, 16 focused on cardiovascular surgery, six on orthopedic surgery, and the other 15 from  
various hospital unit settings (van Meenen, L., van Meenen, D., Rooij, & Riet, 2014).  
Interventions suggested by guidelines for management of delirium were created based on 
general medical care patient data sets (Brown et al., 2017), thus it is a mixed message that risk 





interventions in other settings such as ICU or post CV surgery have not been studied, leaving an 
additional gap in the literature.   
Clinical practice guidelines and organizations such as the American Nursing Association 
(2016) note that assessment of risk is the first step to preventing delirium, yet not one 
recommends a delirium risk prediction model.  It may be attributed to the fact that there only two 
published implementation studies (Brown et al., 2015; Brown et al., 2017) and one impact study 
(Brown et al., 2017).  Impact and implementation studies report on the findings during 
implementation  and show what impact it has on the population.  Significant gaps in literature are 
few studies have been externally validated, more models exist than validation studies, and it is 
rare to find reporting of impact studies or clinical improvement projects with the use of DRPM.  
It is possible that support for implementation of DRPMs in practice would increase if all the gaps 
in literature were studied and published. 
Conceptual Framework: Stetler Model of Research Utilization  
 The Stetler Model of research utilization is the guiding framework for this literature 
review.  It directs practitioners to develop common standards, tools, and policies that are 
supported by evidence-based research.   It guides clinicians in critically reviewing and reflecting 
on practice to understand the relationship between research use and evidence-based practice.   
This model sets criteria and sets standards to view a problem (Stetler, 2001).   
The five phases start with the literature search that guides the structure of evidence 
reported within this review.  The subsequent sections are outlined based on these three phases 
from the Stetler model (2001).  Phases four and five of the model relate to implementation, 
which is not the purpose of this literature review thus were not used for this project.  Figure 1 





Phase one begins with preparations including defining the purpose of the research, the  
context of the studies, and levels of evidence (Gray, Grove & Burns, 2017).  Phase two is the 
validation phase which analyzes of the overall credibility, applicability, and operational details of 
the studies and aids in the evaluation of the fit of each research study to the purpose of the 
inquisition.  Phase three is the comparative evaluation or decision-making phase, the evaluator 
organizes and displays the research findings based on their similarities and differences.  Each 
phase builds on the findings from the previous phase adding depth of understanding of the 
studies.  Phase three ends with recommendations for practice based on the evidence presented.   
 




Preparation for this integrated literature review consisted of identifying the purpose, 
context, and sources of evidence to include in this literature review/comparison study (Gray, 
Grove & Sutherland, 2017).  During this phase the criteria was developed for inclusion: level of 
evidence a model contains, the research method (retrospective or prospective cohorts), the 
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inclusion of developed non-validated studies vs. validated studies, and the population of focus 
for the DRPMs.  This led to the purpose of this review and the guiding questions. 
Phase Two 
In phase two, the overall credibility, applicability, and operational details were assessed.  
Each study was evaluated for the level of evidence and quality of reporting of the study with the 
use of the CHARMs checklist and the Newcastle-Ottawa scale.  During this phase reflection of 
the meaning of each study was done as this author reviewed the variables included in the 
prediction model and its ability to perform its intended purpose.  For ease of comparison 
literature tables were created (Table 12). 
Phase Three:  Review of Studies 
In phase three a comparative evaluation between the selected studies was completed.  
This comparison guided the final recommendations for practice based on the evidence presented 
by the authors of each DRPM.  A table of statistical comparison and the tables outlining the 
factors in each DRPM were created during this phase  (Table 14 and Tables 1-7 respectively).   
Each phase of the Stetler Model builds upon the previous stages, the figure was developed to 
show this relationship and the ability to step from level 1 to level 2 or back up to level 1 again as 
the direction of the literature changes with discovery or new evidence.   
Conclusions 
 
The risks of complications are high for our fragile elderly patients being admitted into 
hospitals.  Reactionary clinical practices are no longer valid in the prevention and treatment of 
delirium.  The costs associated with delirium are not limited only to financial losses, as delirium 
affects the quality and quantity of a person’s life.  Cost and quality of care are leading healthcare 





medical care is changing from treatment of conditions to prevention.  Today, clinical decision 
making for delirium prevention is not aided by DRPMs.  This gap in preventative care exists 
because past models were not feasible to complete in clinical practice.  More attention is needed 
to employ more recently developed models and develop preventative protocols for delirium 
across all acute care hospital settings. 
The seven models included in this review have statistically proven their ability to stratify 
risk.  What they have not proven is clinical effectiveness of DRPMs in practice.  The recently 
published impact and implementation studies show promise in both the use of DRPM in general 
and their use within a delirium prevention care pathway (Brown et al., 2016; Brown et al., 2017).  
DRPM are suggested for use as a clinical decision tool to triage implementation of delirium 
prevention pathway or bundles of care (Douglas et al., 2013).   
Clinical guidelines recommend assessing risk factors however they do not offer 
systematic methods to determine the risk of developing delirium.  The DRPM’s presented in this 
literature review are evidence that stratifying the risk of delirium is possible using validated 
models.  The ability to stratify risk is the key to triaging resources to implement preventive 
interventions that are resource-intensive and expensive.  Stratifying risk and applying 
interventions to those at greatest need has been shown to be cost-effective in implementation 
studies (Brown et al., 2017).   
The conclusions drawn from the appraisal and synthesis of the models and supporting 
literature guide the recommendations for practice.  The conclusions are:  
 The literature shows evidence that DRPMs could be used in clinical practice as part of a 





 Without further published impact studies or quality improvement studies that use DRPMs 
for triaging of interventions the guidelines cannot recommend a tool for use 
 Delirium is a serious medical and psychiatric problem, leading to adverse health events, 
for which preventative measures are stated to reduce the rates, given the 2050 projected 
increase in elderly adults, the time to prevent is now 
 Interventions for delirium should be studied in the population for which the DRPM is 
aimed 
 There are no known risks of the preventative interventions, thus it is assumed that 
implementing preventative pathways can only provide benefit 
 Healthcare needs standardization of the processes of preventing, managing, and treating 
delirium 
 Adding actionable recommendations to a care pathway may provide clinicians with a 
reason to implement interventions and promote acceptance of a model by staff 
 While complex to implement, automated models provide consistency and liberates time 
normally is spent by practitioners calculating a risk score   
Recommendations 
Implementing standardized healthcare processes are best accomplished by the 
development of care pathways or care bundles.  According to the Institute for Healthcare 
Improvement a bundle is,  "a structured way of improving the processes of care and patient 
outcomes: a small, straightforward set of evidence-based practices....that, when performed 
collectively and reliably, have been proven to improve patient outcomes." (Evidence Based Care 





A recommended delirium preventative pathway will include three main elements; (a) an 
evidenced based delirium screening/diagnostic tool with high accuracy rates, such as the 
Confusion Assessment Method (CAM), (b) an automated DRPM, (c) evidence-based delirium 
prevention interventions as recommended by the NICE guideline (NICE, 2010) (or a similar 
guideline) with the addition of stepped interventions that increase in intensity of resource 
utilization as the level of delirium risk increases.  During a personal communication with Dr. 
Douglas, a neurohospitalist from the University of California San Francisco hospital, he stated 
that two mistakes his team made when implementing the AWOL into practice was not using the 
CAM as a diagnostic tool and not spacing the implementation of the NuDESC for delirium 
screen adequately before implementation of the AWOL into practice.  He suggested that prior to 
any implementation of a DRPM or preventative care pathway, a delirium screening tool such as 
the confusion assessment method (CAM) be employed for a minimum of three months (V. 
Douglas, personal communication, May 17, 2018).  Adoption of an accurate diagnostic tool as a 
first step will allow for gathering of clinical data on current delirium rates.   
Educating all staff before the implementation process on the evidence and predictive 
ability of the model may improve the perceived value, increase acceptance, and improve belief in 
the care pathway (Kappen et al., 2018).  Education is priority prior to implementation of any of 
the five elements of a delirium prevention care pathway.  Additional Education on the 
epidemiology, pathophysiology, diagnosed criteria, risk factors, methods to screen for onset, and 
evidence-based interventions for prevention of delirium need to be provided to staff.   
Recommendation for a Specific DRPM 
Automated risk scoring allows for provider notifications of risk levels without increasing 





barrier to implementation.  The GBM (Wong et al., 2018) or the e-Nice (Rudolph et al., 2016) 
are the recommended models, they are automated  scores and have the highest Se and Sp of any 
tool.  Of note the e-NICE is currently implemented without a care pathway at 118 VA hospitals 
(J. Rudolph, personal communication, June 14th, 2018).     
Recommendations for Research 
Decisions to implement evidence-based clinical practices would ideally be supported by a 
large multicenter pragmatic randomized control trial (RCT).  A study of this level assesses the 
strengths of the model, limitations, and its effectiveness as a clinical decision-making tool.   
However, RCTs are difficult to conduct on the effectiveness of care pathways because of 
operational and ethical considerations such as the withholding of effective evidenced-based 
interventions from the control population (Cheah, 2000).  The impact of a DRPM cannot be 
studied independent of prevention strategies because the prediction models use is only to detect 
if there is a risk of delirium and does not provide interventions to effect patient outcome.   
Quality improvement (QI) projects are an integral part of good clinical practice and are 
designed to implement existing evidence-based knowledge to bring about improvements at the 
local level (Kappen et al., 2018).   The AWOL impact study by Brown et al., (2018) is evidence 
that reporting of QI projects produce subject matter knowledge.  The recommendation for future 
practice is that hospitals execute a QI project with the intent to decrease delirium rates and to 
decrease the negative effects on healthcare systems, patients, and families by mitigating the 
severity of delirium.  The QI project would be a unit based project with the implementation of a 
delirium screening tool, a delirium risk assessment model, and evidence-based interventions.  
The study results ideally would be published to allow other healthcare teams to learn from the 





The Stetler Model of Evidence Based Practice was practically employed with the vision 
that this literature review is a launching point to implementation.  Progressing this evidence into 
the fourth and fifth phases of the model could be done as doctoral student or healthcare provider 
to implement a delirium care pathway into clinical practice.  The last two phases of the Stetler 
Model can guide putting research into clinical practice.  Future doctoral students should note that 
the Wong et al., (2018) computer model can be requested for the goal of clinical application.   
Implications for Nursing 
The Institute of Medicine's report in 2000 states that it is the responsibility of every 
healthcare worker to enact evidence-based principles of care to prevent patient harm and most 
clinical risks originate directly from defects or insufficiencies in the healthcare system (Adibi, 
Khalesi, Ravaghi, Jafari, & Jeddian, 2012).  Systematic methods of preventing and managing 
delirium can prevent harm.  Clinicians are the advocates for patient safety and can advocate for a 
systematic delirium pathway with a DRPM used to triage preventative interventions.  This would 
require development of the care pathway, policy changes, education to staff, and data collection 
and analysis on implementation effects.  If DRPMs are used, clinicians, nurses, and hospital 
administrators will be part of the creation of a new paradigm, a shift in the care of a hospitalized 
at-risk patient, with the potential to improve patient outcomes and decrease the cost of delivering 
healthcare.   
For clinicians delirium has many consequences like the patients inability to consent for 
procedures, learn about personal healthcare interventions, participate in therapies, or any 
cognitive interaction.  Family members need to be contacted for consent and illness education 
which may result in a delay in care or extended hospitalizations.  Patients with delirium are 





medical management, increasing their risk of adverse outcomes.  Delirious patients may 
inadvertently cause personal trauma while pulling at or removing medical devices such as 
intravenous catheters, Foley catheters, oxygen assistive devices, and monitoring equipment 
increasing the risk for infections, bleeding, and urinary incontinence; thus, nursing care increases 
as well as the use 1:1 sitters.   Hallucinations and delusions set a patient up for unintentional self-
harm or caregiver harm,  for which physical or medicinal restraints may be applied for safety, 
again increasing nursing care, sitters, and added workload documenting safety.  
Requiring another assessment tool would increase workloads that are already heavy, but 
employment of an automated delirium risk prediction model would mitigate additional work for 
assessments.  The risk level will alert nurses to tailor interventions to meet a patient’s health 
needs based on patient specific risk factors.  Bedside nurses tailor care to meet patient needs as 
part of their nursing processes.  They are in a special position to assess for delirium risk, discover 
onset of delirium, notify providers of the onset, and intervene with the tailored evidence-based 
preventative strategies.  An example is enacting a tailored plan to treat a disturbed circadian 
rhythm due to nursing activities over-night.  The nurse modifies timing of assessments and  
interventions, matching a patients sleep cycle; this may require calling clinicians to allow for 
decreased checks on vital signs or overnight nursing assessments.   A second example is 
mitigating the effect of sensory deficits by encouraging the use of hearing aids or glasses during 
the day.   
 A clinicians role varies from a nurses role in that in response to level of risk for delirium 
a clinician would weigh the risk and benefit of procedures, medical tests, and medications 
against the potential triggering of iatrogenic delirium.  If the onset of delirium is reported or 





diagnoses and choose the appropriate medical interventions to treat the underlying cause.  
Clinicians can consult geriatricians, psychiatry, physical therapy, and pharmacy for their 
recommendations on preventative strategies and management of patients delirium.  Directing 
nursing non-pharmacological management and ordering frequent assessments on mentation and 
ability to perform ADLs.   
This integrated literature review has far-reaching implications for healthcare's ability to 
prevent the harmful effects of delirium by improving recognition of a patients risk for delirium, 
understanding that it is often preventable through the implementation of delirium prevention 
interventions, and prevention of delirium improves the quality of care to every hospitalized 
patient by decreasing adverse events associated with it.  The World Health Organization (WHO) 
defines health as "a state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity (“Constitution”, para 1.).  The World Health Organization defines 
health promotion as the process of “enabling people to increase their control over and improve 
their health” (What is health promotion, para. 1).    
According to the IHI, the triple aim for healthcare is an approach to optimize healthy 
system performances by improving the patient experience, health of populations, and reducing 
the per capita cost of care (IHI, 2018).  The role of healthcare providers is to maintain health, 
thus preserving the quality of life.  Delirium negatively impacts patient and family healthcare 
experiences as it results in poor health outcomes and increases the cost of healthcare.   
Summary of Conclusions, Recommendations, and Implications for Nursing 
The aim of using a DRPM in clinical practice is to stratify the risk for incident delirium 
allowing clinicians to target those at the most risk with the preventative interventions.  One 





triage the interventions, allowed for efficient use of resources.  This implementation study 
reported a decrease in length of stay, 30-day readmission rates, and severity of delirium.  The 
literature shows that DRPMs are able to stratify the risk of delirium and when included in a 
preventative care pathway effectively mitigate some repercussions of incident delirium.   
Automated models have been developed in response to the barriers of adoption and 
implementation of DRPMs.  After integration in computerized charts, automated models are the 
most feasible models because the result is available to the provider without additional time added 
to their workflows.  The electronic versions of the e-NICE by Rudolph et al. (2016) and the 
Wong et al. (2018) models were statistically superior to all of the other models; they are 
technically complex, with the GBM containing hundreds of predictors mined from the 
computerized charting system (Wong et al., 2018).  The Wong et al. study notes that if requested 
other researchers or healthcare systems seeking quality improvement of delirium care can request 
the computer program that the researchers developed and allow the use by another healthcare 
system.  The DSS (Pendlebury et al., 2016b) shows promise for use in healthcare facilities where 
integration into an electronic medical record is not possible with its feasibility and accuracy of 
stratification.   
The AWOL and e-Nice tools are the only tools reported in research that are clinically 
employed at this time.  The AWOL tool was employed as part of a care pathway and was studied 
in three follow up studies, the Brown et al. (2017) impact study, Pendlebury et al., (2016a),  and 
the Wong et al. (2018).  It is available in the computer application called MdCalc, but this is not 
tied into the computer systems and clinicians still need to actively seek the risk score, again 
creating unreliability.  The e-NICE tool is in current use in clinical practice at the VA medical 





The Gradient boosting machine by Wong et al. (2018), is a tool with the highest 
sensitivity and specificity of all delirium risk stratification models.  It is an electronic model that 
automatically uses data abstraction to electronically stratify every admission for delirium risk. It 
contains over 300 predictors, thus is the most comprehensive, and has the highest AUC of any 
delirium risk prediction model at .855, however this model is very complex. Neither the GBM 
nor the e-NICE have been implemented in tandem with a delirium prevention bundle.  
 Gaps in practice include lack of implementation and impact studies to provide clinical 
evidence of the effectiveness of the models.  There are no studies showing which interventions to 
employ at each risk level which may increase the effectiveness and decrease use of unnecessary 
resources.  Generalization of DRPMs are difficult related to their narrow focus of population and 
the fact that some are not externally validated.  DRPMs are created to aid clinical decision 
making of healthcare providers, however, no studies examining their effect on clinical decision-
making exist.   
The primary studies of the DRPMs show validated statistical proof that they have the 
ability to stratify risk.  The impact and implementations studies provide literature supporting 
their use within a care pathway.   HELP interventions have shown to decrease delirium rates and 
NICE guidelines recommend similar interventions without the use of hundreds of volunteers.  
The main recommendation is to implement a full delirium prevention pathway.  A DRPM will 
allowing triaging of the interventions within the pathway to deliver necessary preventative care 
to decrease risk, decrease adverse outcomes associated with delirium, and ultimately improve the 
quality of care given to patients.  The process and result of implementation should be studied and 
published to begin to close the gap in evidence of clinical effectiveness of their ability to stratify 





In summary, optimal models must have the ability to discriminate, calibrate,  and are 
validated in the clinical practice setting adopting the model.  To be useful in practice (feasible), 
predictors must be readily available at the time of admission, or shortly after (same day), and 
cannot require additional medical testing or complex assessments.  The more recently created 
and validated primary delirium risk prediction models have proven feasibility in their less 
complicated predictors. The risk assessment must be completed as early as possible after 
admission to allow for the implementation of preventative measures before insults occur that 
further increase the risk of delirium.  Delayed risk assessment results in a lost opportunity to 
preventative delirium.  Improvement in provider reception of a risk prediction model may follow 
the recommendation for an automated risk prediction score because of the liberation of a 
provider's time.  These automated models also show a statistical improvement in stratification 
accuracy compared to the non-automated models. 
Delirium is a medical emergency with consequences of death and disability, similar to a 
stroke or a myocardial infarction. There are no cures for delirium; healthcare providers must take 
action in the fight to prevent its onset.  We cannot wait for the creation of the perfect model or 
care pathway.  The healthcare system continues to dismiss evidence that a care pathway (such as 
the ABCDEF bundle or the HELP) can prevent delirium, which results in patient harm, family 
burdens, and rising healthcare costs.   
The current practice of assessing risk by clinical intuition and experience allows for vast 
variations in practice. As evidenced by the high delirium rates in our acute care facilities it is also 
very inefficient. Therefore, a systematic method needs to be employed to consistently stratify the 
risk of every patient admitted to a hospital. The recommendation for application in clinical 





management care pathway.  A DRPM can be employed to triage the hospital's limited resources 
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e-NICE: Rudolph et al., 2016 
 
Risk Factor Abstraction Terms Score 
Cognitive Impairment 
(positive if one term 
present) 
Dementia, Alzheimer’s Disease, Poor Historian, Memory loss, 
Unarousable, Uncooperative, Demented, Delirium, Change in 
mental status, confused, Encephalopathic, Disoriented, 
Lethargic, Obtunded, Stuporous, Combative,  
 
Sensory Impairment 
(positive if one term 
present) 
Visual loss, Blindness, wears glasses, Hearing impairment, 
Hard of Hearing, Wears hearing aids, Presbycusis 
 
Dehydration (Positive 
if BUN/Creatinine ≥18) 
BUN, Creatinine  
Severity of illness 
(positive if 2 terms 
present) 
Age>60, Metastatic Cancer, Lymphoma, Leukemia, AIDS, 
RR > 25, Systolic blood pressure <100 mmHg, Pulse >120, 








Low  0  
Medium  1-2  


































AWOL: Douglas et al., 2013 
 
Variable: Score 
Age ≥ 80 =1   
Ability to spell WORLD backward=1  
Disorientation to place = 1  
Nurse rated illness severity = 1  



































Delirium Prediction Score (DPS): Carrasco et al., 2014  
 
DPS= (5 X BUN (mg/dl)/Creatinine (mg/dl) ratio) – (4 x Barthel Index)  









Martinez et al. 
Variable: Score 
 Age ≥85  
 Functional Dependence 
• Living at a care center or at 
home with homecare 
 
 Diagnosis of Dementia  
 Total >1  
 
Isfandiaty et al. 
 
Cognitive Impairment =3 
 
 Functional Dependence = 2 
• Living at a care center or at 
home with homecare 
 
 Infection without sepsis =1 
Infection with sepsis (SIRS≥2)= 2 
 
 Total >3  
 
Douglas et al. 2013 
(AWOL) 
 
Age ≥ 80 
 
 Dx of Dementia or low cognitive score 
as defined by this study (2 points) 
 
 Illness severity (nurse assessment)  
 Total ≥2  














Delirium Susceptibility Score: Pendlebury et al., 2016b 
 
Variable: Score 
Age ≥ 80 =2  
Cognitive Impairment = 2 
(MMSE <24 or AMTS<9 or known dementia) 
 
Infection =1 
Infection with sepsis (SIRS≥2)= 1 
 
Visual Impairment= 1  
Total ≥ 5  
 
Table 8   
 
Delirium Prevention Links 
 
Resource                   Website 
American Nurses 
Association Delirium 







National Institute for 











The American Geriatrics 
Society (post-op delirium) 
 
 
American College of 
Critical Care Medicine/ 




The American Association 
of Critical Care Nurses 










































IM MD to dx 
delirium, low rate 
of delirium)  
*(Follow up not 
necessary in this 
study type) 
5/7 







CAM for risk 
factors) 
* 6/7 

















*** ** * 6/7 
Rudolph et al., 
2016 
 










Wong et al., 
2018 
 






low rate of 
delirium r/t ages 







Table 9, Cont. 
 
Newcastle Ottawa Scale for Quality Assessment Explanation. 
 
Selection One max: 4 stars 
1) Representativeness of the exposed cohort 
 a. Truly representative of the average delirium study in the community* 
 b. Somewhat representative of the average in the community* 
 c. Selected group of users (e.g., nurses, volunteers) 
 d. No description of the derivation of the cohort 
2) Selection of the nonexposed cohort 
 a. Drawn from the same community as the exposed cohort* 
 b. Drawn form a different source 
 c. No description of the derivation of the nonexposed cohort 
3) Ascertainment of exposure 
 a. Secure record* 
 b. Structured interview* 
 c. Written self-report 
 d. No description 
4) Demonstration that outcome of interest was not present at start of study 
 a. Yes* 
 b. No 
Comparability (max: 2 stars) 
1) Comparability of cohorts on the basis of the design or analysis 
 a. Study controls for _________ [select the most important factor]* 
 b. Study controls for any additional factor* 
Outcome (max: 3 stars) 
1) Assessment of outcome 
 a. Independent blind assessment* 
 b. Record linkage* 
 c. Self-report 
 d. No description 
2) Was follow-up long enough for outcomes to occur 
 a. Yes* 
 b. No 
3) Was there adequacy of follow-up of cohorts 
 a. Complete follow-up = all subjects accounted for* 
 b. Subjects lost to follow-up unlikely to introduce bias (e.g., small number or percentage lost) 





















I Evidence from a systematic review or meta-analysis of all relevant RCT;s (randomized controlled 
trial) or evidence-based clinical practice guidelines based on systemic reviews or RCTs or three or 
more RCTs of good quality that have similar results.  
II Evidence obtained from at least one well-designed RCT (e.g. large multisite RCT) 
III Evidence obtained from a well-designed controlled trial without randomization (i.e. quasi-
experimental). 
IV Evidence from well-designed case control or cohort studies.   
V Evidence from systematic reviews of descriptive and qualitative studies (meta-synthesis).  
VI Evidence from a single descriptive or qualitative study.  
VII Evidence from the opinion of authorities and /or reports of expert committees.  
 
Note:  This level of effectiveness rating scheme is based on the following: Ackley, B.J., Swan, B. A., Ladwig, G., & 
Tucker, S.,  (2008).  Evidence-based nursing care guidelines: Medical-surgical interventions. (p. 7). St. Louis, MO: 
Mosby Elsevier 
Note: In the literature review tables (Table 12), the single asterisks * indicate studies of the models critiqued and 






















Supporting evidence Level of 
Evidence 
Study design 
AWOL Douglas et al., 2013 
 
Wong et al., 2018 
 
Pendlebury et al., 2016a 
 















e-NICE Rudolph et al., 2016 
 









Wong et al., 2018 
 
IV Retrospective cohort 
CHAID Decision Tree Kobayashi et al., 2013 
 
IV Retrospective cohort 
Delirium 
Susceptibility Score 




Isfandiaty et al. Isfandiaty et al., 2014 
 









Martinez et al., 2012 
 

























































































based on the previous 
Inouye (1993) 
developed prediction 
rule that included 
cognitive impairment, 
sensory deficits, 
severity of illness 
(APACHE II), and 







admission and daily to 
Dx based on DSM-IV, 
Charlson Comorbidity 
Index, (not APACHE 
due to increase need 
for labs costly) 
BUN:Creat ratio 
Chart review for 
sensory deficits and 
cognitive impairments 
-Chart abstraction took 2 
minutes 19 seconds 
-Delirium + in 23% with 
incident in 14% (prevalent 
9%) 
-cognitive impairments 
correlated low MMSE score 
-Higher Charlson 
comorbidity index scores 
correlated with chart 
identified severe illness.   
59% had sensory 
impairments. 
-more risk factors correlated 
with delirium dx was 
statistically significant (X² = 
9.2, df=2, P=0.01.   
C statistic 0.65, 95% CI= 
.54-.76 
prevalent delirium removed 
then the rate was not 
significant (X² = 1.3 , df=2, 
P=0.53.   







- simplicity to use 
-automated chart 
abstraction tool to 
rate delirium risk 
for real-time 
decision support 
to prompt targeted 
interventions.  
-Limitations were 





Dx of delirium 
by a geriatrician  
MMSE daily is 
time consuming 
 
rates of delirium 
correlate with the 
study by Inouye 




Index not as 
effective as the 
APACHE II.   
Generalizability 
limited due to 
single setting, 
white male  
 
Predict prevalent 























































aged 60 and 









Retrospective cohort  
-March thru April of 
2011.   
-prevalent delirium 
excluded 
-Variables in the 
development cohort 
included: 12 predictors 
derived from previous 




decrease in functional 
status (Barthel index), 
stroke, metabolic 
disturbance, heart 
disease, infection with 
and without sepsis, 
and hypoxia  
-Md DX delirium- no 
screening tools noted.   
Data analysis via 
SPPS 17.0 with SD 
-Cox hazard: to 
determine indep 
predictors.  
-Missing data: imputed 
87 pts experienced delirium 
out of 475 patients=18.8% 
--no delirium= 75.5%- mean 
survival is 11.8 days 
without 
 -59.3% of delirium 
occurred within the first 3 
days, and 81.4% within the 
first 7 days of admission.   
 
Missing variables dealt with 
by Estimation and 
Maximalization (EM) to 
impute missing data to 
maintain study power- this 
method is preferred to 
excluding data. 
 
Cox proportion hazard 
method showed infection, 
decreased function status 
and cognitive impairment 
the 3 indep predictors.  
 
Logistic regression used to 
determine model based on 3 
predictors.   
Hosmer-Lemeshow test P 
value 0.066 and AUC 0.823: 
CI 95% 0.776-0.877) 
 
 
-risk of delirium 





delirium in the 
first 14 days of 
admission 
-this study shows 




backs this up.  
20.2% of pts had 
cognitive impair. 







model to apply 













however this is 
not explained nor 












sepsis was the 
greatest rated 






























al., 2012.  
Derivation and 























































Cohort original study 
 
Outcome: delirium  
dx: CAM  
18 or over, May 1st-
June 30th, 2008 and 
2009 
Admitted to medical 
units.   
Independent 
researchers reviewed 
charts for delirium 
with dx by MD 
  
Validation model 
predictors: age 85 or 
greater, level of 
dependence (more 
than 5 areas of 
dependency) 
, psychotropic 
medication (2 or 
more)- each one point 
 
Final model: result 
positive if 1 or more is 
the score.   
Used the Hosmer 
Lemeshow test  
 
ROC curve analysis 
 
2x2 table sensitivity of 
93.4%  
CI 85- 97.2% 
specificity 60.6%  
95%CI: 54.4- 66.8%  
PPV 44.4%, 95% CI 36.9-
52.1% 
NPV 96.5% -95% CI-92-
98.5% 
 
Those in the Validation 
cohort were significantly 
more dependent for ADL’s 
validation cohort the AUC 
is 0.85 
-classify around 53% of this 
cohort as high risk, limiting 
interventions to this 53%, 
covering 93.4% that did 
develop delirium.   
 
DX of delirium cases may 
still have been missed as an 
internal medicine md dx 
it/not a psychiatrist   
 
3 independent risk 
factors were age 
85 or older, 
dependent in 5 or 













insults, none of 
the later are 
included in this 
risk model.   
 
Limitation: Dx of 
delirium by IM 
MD and not a 
psychiatrist thus 
some patients may 
have been 
undiagnosed.   
Ease of use 
would increase 











model is too 
general and 
includes more 




Basic model, all 






























































































CAM to assess for 
outcome of delirium 
within 6 days of admit 
 
4 items were assessed:  









was derived in both 
cohorts (P <0.001 in 




AUC derivation cohort 
was 0.81 (95% CI 
0.73-0.90) and 




Predictors entered into 
stepwise logistic regression 
analysis and ID’d 4 indep. 
Predictors of delirium in the 
derivation cohort.   
Each assigned a value of 1 
pt. 
The higher the score the 
higher the rates for delirium 
in the derivation cohort.  
40% of the patients in risk 
category 3-4 developed 
(P<0.001) delirium, and 0 in 
the 0 score.  
Validation cohort occurred 
at the VA- more male than 
the derivation cohort. 
 
Completed in <2 minutes by 
RN staff- developed for 
bedside RN  use! 
 
This tool characterizes 
medical pts at risk at the 
time of admission and could 
be used in trials of delirium 





assistants and a 4th 
year medical 
student screened  
 




The validation in 
a VA setting is 
also clinically 




usefulness.   
-external 
validation of a 
larger cohort is 
needed to 
determine why 0 
were delirious in 
level 4, is the tool 
sensitive and 
specific – should 
show higher % 
with delirium in 
this level. 
Ease of use 
 
Bedside RNs 




labs or intricate 
assessments 
 




































































2009-10 at St. Luke’s 
community hospital 
Tokyo Japan. Internal 
med unit 
-Predictor variables for 





-Predictor variables for 
logistic(5) Age, hx of 
delirium, dementia, 
malignancy, EtOH 
abuse, and ADL 
impairment 
-Providers and nurses 
monitored for delirium 
Dx of outcome made 
by DSM IV 
-Data mining 
technique-CHAID and 
a logistic regression 
were compared to find 
the best model. 
-SPSS software used 
for analysis except for 
CI computed by Stata 
version10 
CHAID Validation AUC  
0.82 (95% CI:0.77-0.86) 
 
Divided into 6 levels of risk, 
quite low, low 1, low 2, 
moderate, high, and quite 
high- when broken down the 
delirium rates climbed as 
each level increased 
 
The logistic regression 
model showing all variables 
included to be significant 
Validation AUC =0.79 
(95% CI:0.72-0.86) 
 
Ease of use noted.   
 
3.8% developed delirium in 
derivation group, and 4.2% 
in the validation cohort 
 
Significance level 
can be modified 
to fit number of 
comparisons. 
 




lead to elevated 




a tool such as this 
 
Pts monitored by 
RN and MDs for 
delirium on set, 
however no tools 
used like the 






to absorb the 2 
highest risk 
levels and the 2 
lowest risk levels  
 
CHAID can be 
broken down to 
ages and a score 
for children can 
be derived too. 
This tool is noted 
to be easy and 
flexible with use 
of data  
  
One of the only 


































































































analysis with a p<0.05 
included in 
multivariable model as  
 
-Outcome- MD 
documentation of Dx.  
Use of Delirium 
Rating Scale and 
Delirium Obs scale to 
aid in Dx.  No use of 
DSM criteria.  
 
Medication and age 
model preformed as 
well as the full model 
to suggested validation 
of the medication 
model as it requires no 
labs.   
 
Compared 2 developed 
prediction scores.  Addition 
of clinicals was irrelevant to 
the accuracy of the 
prediction model, thus they 
opted for the simplest model 
containing only age and 
Medications 
 
AUC of the full predictive 
model-0.78 
 
AUC of the medication 
model-0.76- addition of lab 
values did not provide 
additional benefit and many 
lab values missing-state that 




Some studies state 
prevalent delirium 
is onset within 48 
hours here it is 24 
hours.  
 
Not generalizable  
due to study 
setting.   
 




in this country 
may vary greatly 
than others thus 
may not be 
predictors of 




models can cause 
overfitting 
equaling elevated 
AUC score and 
predictive 
capability 
Study done in 
Netherlands in 
one setting.   
 
 
EMR used to 
evaluate risk 
prediction in 




note that risk 
factors that are 
typically 
significant in 
other studies are 
not significant 
indicators in this 
study.  Which is 
concerning for 
accuracy of data 
and were pts 
accurately dx 
with delirium? 
Dx based on 
DRS and DOS, 
whereas most 















































and the next 











































-Model update study 
of 4 existing tools 
- CAM and DSM IV 
criteria. 
-Cohort 1 used MMSE 
within 24 hours <24 
positive cog impairs 
Cohort 2 used AMTS 
<9 positive cog 
impairs 
-Delirium rates noted : 
28/95 incident.  
-prevalent and incident 
delirium 
-Gathered data on 
demographics, admit 
complaint, potential 
risk factors, hx of 
dementia, 
vision/hearing deficits, 
VS, SIRS score.   
-acute medicine pts.  
-Sensitivity, 
specificity, PPV, NPV 
were measured as well 
as the AUC. 
Studies included: 
Inouye et al., 2007  
Martinez et al., 2012 
Isfandiaty et al., 2012 
Douglas et al., 2013 
 
Unable to include Carrasco 
et al, 2014, no ability to 
complete Barthel index 
 
Results: 
AUC 0.73-0.83 for incident 
delirium.   
All scores performed better 
than chance,  
-no superior tool is found all 
relatively equivalent. 
 
Noted that these can 
facilitate targeting of 
multicomponent 
interventions.   
May help recognize risk, 
improve dx of delirium.   
 
 
Superior study in 
the framing and 
reasoning for use 























altered to fit data 
obtained by this 
patient group 





here was a 1.   
 
Externally 
validated 4 tools 




needed.   
 
Interested to see 
if there is an 
impact study to 

























































for use at entry 













































-September to Nov 
2010 and again April-
June 2012  
-Screened for outcome 
with CAM, dx with 
DMS-IV by MD  
-Tripod guidelines 
followed for 
development of a 
prediction tool.   




AUC was 0.81 (0.70–
0.92), for incident 
delirium;  
odds ratios (ORs) for 
risk score 5–7 versus 
<2 were 17.9 (5.4–
60.0), P < 0.0001 for 
any delirium, 8.1 (2.2–
29.7), P = 0.002 for 
prevalent delirium, 
and 25.0 (3.0–
208.9) P = 0.003 for 
incident delirium, with 
corresponding relative 
risks of 5.4, 4.7 and 
13.  
 
Detects prevalent and 
incident delirium 
 
Pragmatic/Simple tool.  
 
DSS had higher AUC than 
any other previously tested 
model (previously tested in 
this cohort), but once AUC 
accounted for the correction 
for multiple comparisons 
the AUC was generally 
comparable.  
 
Simplified form of the 
previous scores- derivation 
of new prediction score in 
this article.   
 
Each risk factor was 
removed, and AUC was 
analyzed to determine 
necessity of the risk factors.  
Vision is the only one that is 
non-significant, however 
removal of age >80 was 
removed AUC improved to 









face validity of 
this tool 
 
Preformed as well 
as other prediction 
scores previously 
compared in the 




on multi center 
risk factors and 
previous studies 
derived based on 




in this study was 
robust due to 




be automated in 
the EMR.    
 
Developed as a 
diagnostic and 
prognostic 
























































































final.   
 
Ages 50 & > 








Retrospective cohort / 
IMPACT study 
 




Variable was addition 
of prevention plan for 
a score of ≥2.   
 
Compared outcomes 
(delirium) before and 
6 mo. after 
implementation of the 
delirium care pathway 
which included 
interventions aimed to 
prevent delirium.   
 
 
ROC curve analysis 
completed, sensitivity 
and specificity noted.  
 
 
Those with AWOL score of 
0 =5.45% delirious with 
3.11% with incident 
delirium. Score of ≥2 60.5% 
delirious, with 25% having 
incident delirium. 
 
AUC for incident delirium 
only was 0.73 (95% CI 
0.60-0.85).   
 
incident delirium only group 





Only 46% of patients were 
scored!  Need for increased 
education to staff prior to 
next IMPACT study.   




this model has 
successfully 
stratified patients 
into high and low 
risk- resources 
can be allocated 
when needed. 
 




continue to be 
assessed to 
prevent missing 





thus needing to 
eval more closely 
those ID’d @ 
higher risk to 
ensure delirium is 
not present.   
Less sensitive 
due to the factors 
do not account 
for all the risk 
factors of 
delirium or 









of the care 
pathway.   
 











































of a Delirium 
Predictive 




















































prospective cohort- to 
develop and validate a 
score. 
 
CAM within 48 hours 
and every 48 hours 






functional status and 
laboratory data.   
 
Final tool included: 
Barthel Index used for 
functional status and 
BUN to assess for 
dehydration.  No other 
risk factors were found 
to be statistically 
significant to add to 






The authors devised a 
formula to result the 
Delirium Predictive risk 
Score (DPS) = 
(1370 X BUN 
(mmol/l)/creatinine (µmol/l) 
ratio)- (4 x Barthel Index). 
 
Or conventional BUN and 
Creatinine measures the 
DPS= [5 x BUN 
(mg/dl)/creatinine (mg/dl)]-
(3 x Barthel Index)  
with cutoff point -160  
 
AUC for development 
cohort 0.86 (95% CI: 0.82-
0.91) 
For cut off value of -240 & -
160 due to its high 
sensitivity and specificity.   
AUC for validation cohort 
0.78 (95% CI: 0.66-0.90)- 
higher than many tools 
noted thus far! 
 
+ LR 3.4 
-LR 0.16 
 




with best practice 
once per shift.   
 
Language was not 
a barrier for 
enrollment! 
 
Barthel Index is 
noted to be based 
on the patients 
function status 2 
weeks prior to 
admission,  RN 
could assess with 
patient or family.   
 
Noted that its 
negative LR is 
0.16 showing it is 
very good a 
predicting who 



































































































-over the age of 60 
assessed every 24 
hours.  
-Retrospective chart 
review was done to 
chart check for 
delirium. 
-Variables: age, 






analgesia and sleeping 
tables 
-Applied hospital wide 
-Original model AUC 









Scale) used to 
determine delirium- 
 





(better than reported in 
original study) 
PPV from 43.2% (day 1) to 
64.8% on day 5 
NPV from 96.9 (day 1) to 
93.4% day 5.  
AUC- was not tested 
 
Simplified models can result 
in overfitting 
 
Medication classes were 
included not specific 






Dx of delirium 
based on chart 
reviews and audits 
for key words- 
could cause false 











of this developing 
facility and 
outside of the 
Netherlands. 
 
Focus is mainly 
on medications on 
MAR the day 
prior onset, some 
medications have 
a cumulative 
effect such as 
anticholinergics  
 
Weakness, pts is 
asked 3 
questions prior to 
any screening for 
delirium is done, 
if these questions 
are all negative 
then screening 
for delirium is 
not done! 
These questions 










listed not the 
























































































x2 derivation and 
validation cohorts.  
Outcome: delirium 




included in derivation 
cohort and 11752 in 
validation 
 
Compared to the e-





sodium level, and  age 
80 or greater.   
 
Predictors obtained 
through the NICE 
guidelines and 
developed too from 
the most independent 
risk factors 
Developed and validated 
this tool.   
Compared this tool to the 
eNICE and Pendlebury DSS 
2016b with higher 
discrimination in this tool 
then them.   
 
AUROC, 0.91; 95% 
CI:0.91-0.92;p<0.001-high 
discriminatory value  
 
Cognitive impairment was 
the most important factor 
followed by infection, 
sodium level, then age.   
 
Delirium upon admission in 
devel. Cohort=8.5% and 
validation cohort=7.0% 
 
Increasing score was 
correlated to increased rates 
of delirium in all tools.  
 
3 levels of risk, low (0-2) 
Intermediate (3-4) and high 
(5-6) 





risk factors- NICE 
 











Could be added to 
EMR, flags for 
teams could be 
instituted 
9however be 




use of a risk 
assessment tool 
are recommended 




this tool has 














forest test for 
predictors  
 




generalizability.   
 
HIGH proportion 
of men due to 



































tool for the 
identification 
of delirium 




























































model was used  
-Indep predictors were 
age, incontinence, 
urinary catheter, 
ETOH abuse, hx 
dementia, ability to get 
OOB, insomnia, and 
social risk. (all 
included in final 
model).   
-Univariate logistic 
regression for 
associated variables    
-Lasso technique to 
ensure no overfitting 
and generalization  
-cross validation x9 
was for validity of 
model  
-Final model, 
goodness of fit 
(p<0.001) by Hosmer-
Lemeshow test.   
 
 
increase identification of 
risk factors through the 
nursing assessment for a 
care team focus to 
personalize plans for 
vulnerable patients to 
prevent or manage delirium 
 
Highly sensitive, specific, 
and high AUC showing 
reliability 
AUC- the AUC was 0.945 
(95% CI: 0.922-0.970) 
AUC when applied to test 
set was 93.3. 
Sensitivity for predicting- 
94.6% and specificity to 
predicting absence 89.4%. 
 




Needs to be externally 
validated in similar 
populations.   
 
Populations included 
surgical and medical 
patients (GS Trauma 
Urology IM neurology and 
other medical specialties.   
 
Use of RNs 
typical assessment 
could be 
expanded to an 
EMR tool that 
would signal a 
best practice alert 
to staff and 
clinicians – 
alerting to high 
























of care increases 













fragility.   
 

















































































the first 24 
hours 

















only.   
Retrospective Cohort 
-5 machine learning 
algorithms to predict 
delirium using 345 
clinical variables 
available in EMR 
upon admission: 
Demographics, dx, 





Exclusions: AMS or 
confusion, ICU/ ICU 
admit, GCS verbal <4, 
ICD9 code for 
delirium or psychosis, 
NU-DESC  positive 
CAM≥1.Any  
intervene. to prevent 
or treat delirium 
excluded 
Outcome: delirium by 
NuDESC or CAM 
ICU by nurses every 
12 hours. 
Gradient boosted Machine 
model: AUC 0.855 
SET Specificity of 90% 
(95% CI:89-90.9%) 






Number to screen 4.8% or 
191 cases was missed.   
 
4 models compared 
including the AWOL 
This tool can be 
adjusted based on 
clinical need for 
specificity or 
sensitivity- would 
be great to code 





initiate due to 
cost/staff 
resources.   
 
This center uses 
AWOL already to 
screen so use of it 
to compare this 













analysis.   
 
Code provided 
on another link 
site for others to 
validate. 
 
Ease of changing 








Table 13  
Table of Charms Checklist Data 
Domain Key items page # 





DELIRIUM IN THE 
OLDER ADULT 
INPATIENT” 
Lindroth et al., 2018 
 
 
Source of data (e.g., cohort, case-control, randomized trial participants, or registry data): 
 
PubMed, CINHAL, PsychINFO, SocINFO, Cochran, Web of science and Embase were searched from 
January 1990 to December 31st 2016.   
AIM:  Through a systematic review, provide important recommendations on study design for future 
delirium prediction models while integrating knowledge gained from the study of both medical and 







Participant eligibility and recruitment method (e.g., consecutive participants, location, number of 
centers, setting, inclusion and exclusion criteria) 
 
Inclusion: age >60 years, inpatient hospital setting, developed/validated a prognostic delirium 
prediction model, publication dates of 1 January 1990–31 December 2016 
Exclusion: alcohol related delirium, sample size less than 50, population noted as Emergency room, 
palliative care and hospice, ICU, skilled nursing facilities.   
A delirium prediction model was defined as a statistical model that either stratified individuals for 
their level of delirium risk or assigned a risk score to an individual based on the number and/or 






Inclusion criteria: age >60 years, inpatient, developed/validated a prognostic delirium prediction 
model. Exclusion criteria: alcohol-related delirium, sample size ≤50.  
Twenty-three delirium prediction models were identified, 14 were externally validated and 3 were 
internally validated. The following populations were represented: 11 medical, 3 medical/surgical and 








Variables Extracted: study characteristics (study design, population and sample size), outcome 
measure (method of identification and diagnosis, frequency and length of screening), model 
performance information including the diagnostic accuracy of the delirium prediction models, 
calibration metrics and events per variable (EPVs), characteristics of the models (variables used in 
model and scoring/stratification system), cognitive measures used in the study and statistical methods 
applied for analysis. 
 
Details of treatments received, if relevant-NA 
 
 





Definition and method for measurement of outcome 
Outcomes in this study were: Study characteristics, outcome measure (method to dx, frequency and 
length of follow up),  diagnostic accuracy of the delirium prediction models, calibration metrics and 
events per variable (EPVs),  characteristics; variables used in model and stratification system, 





Was the same outcome definition (and method for measurement) used in all patients? 
Calibration: Goodness of fit/ Hosmer-Lemeshow test- agreement between observed outcomes and 
predictions 
Discrimination: AUC 
Clinical utility: Sensitivity, specificity, positive/negative predictive values, OR’s, relative risk, AUC or 
clinical utility curve noting model cut off values 






Type of outcome (e.g., single or combined endpoints) 
Data extraction and comparison between tools- is there 23 or 27 models?   
The average NOS quality ranking for included cohort studies was seven; six studies received the 





Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)? 
No mention of blinding 
 
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)?  No, the 
candidate predictors were not part of the outcome of this review, this review focused on content of 









No follow up needed in this study as they were evaluating studies for recommendations for future 
studies.     
CANDIDATE 
PREDICTORS  
(OR INDEX TESTS) 
Number and type of predictors (e.g., demographics, patient history, physical examination, additional 
testing, disease  characteristics) 
1. outcome measure (method to dx, frequency and length of follow up)  
2. diagnostic accuracy of the delirium prediction models, calibration metrics and events per 
variable (EPVs)   
3. characteristics which included variables used in model and stratification system, cognitive measures 





Definition and method for measurement of candidate predictors 
 
Outcomes measures:   
Characteristics of studies were reported and compared, as was tool to dx delirium, Model design or 
statistical methods, variables used in each study (most common Pre-existing impaired cognition, 
sensory impairment, old age, impair ADL’s, Illness severity, Infection, history of alcohol use,  
Predictive ability:  reported as the AUC with a table showing each 
Model calibration: Chi-square statistics and if they had calibration plots or slopes 
EVPs to determine overfitting-Models estimating more parameters than events in a 1:10 ratio are at 
risk of statistical overfitting, potentially leading to overly optimistic model performance 
Clinical Utility: OR’s, RR, Sensitivity and specificity, ROC curves, R² and  integrated discrimination 






     3-16 
Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment initiation) 
Note discussed as each of these are measured within each study.  Predictors not critically evaluated in 
this systematic review. 
 
Were predictors assessed blinded for outcome, and for each other (if relevant)? NA-Not relevant  
Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or 
categorized)  NA- not relevant 
 
SAMPLE SIZE 
Number of participants and number of outcomes/events 
27 or 23 studies were reviewed, medical and surgical included, all had 50 or more for the same size to 




       2 
Number of outcomes/events in relation to the number of candidate predictors (Events Per Variable) 







Number of participants with any missing value (include predictors and outcomes) 
Each study reported their own missing data; however, this study did not comment on this which would 





Number of participants with missing data for each predictor-NA NA 




Modeling method (e.g., logistic, survival, neural network, or machine learning techniques)  
Model design and methods between the models were compared and they noted how many studies used 
which techniques i.e.: 12 used univariate or bivariate analyses, 5 of these used bootstrapping 
technique to address low sample size and event size.  Noted it was common to have narrow validation 
studies, in which external validation is needed for risk of bias is possible.   
 
4-5 
Modelling assumptions satisfied-N/A  
Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate 
predictors, pre-selection based on unadjusted association with the outcome) 
This review does not create a model it simply recommends inclusions for future research 




      3-16 
Method for selection of predictors during multivariable modeling (e.g., full model approach, 
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion) 
This was compared between models included in this study 
NA 
Shrinkage of predictor weights or regression coefficients (e.g., no shrinkage, uniform shrinkage, 




Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test)  
Discrimination  (C-statistic, D-statistic, log-rank, AUROC) measures with confidence intervals 
Discussed in context of combined models, Table B9 is a comparison of the AUROC for each model 





Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification 
improvement) and whether a-priori cut points were used 




Method used for testing model performance: development dataset only (random split of data, 
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation (e.g. 






Discussed in context of combined models- model performance was assessed through calibration and 
classification metrics 
Clinical utility statistics such as sensitivity, specificity, positive predictive values, negative predictive 
values, ORs, relative risk statistics and use of decision curve analysis or clinical utility cure analysis 










 with delirium total Without delirium   
 
 
In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated, 
predictor effects adjusted, or new predictors added) 
 





Final and other  multivariable models (e.g., basic, extended, simplified) presented, including predictor 
weights or regression coefficients, intercept, baseline survival, model performance measures (with 
standard errors or confidence intervals) 
This was also not discussed but pertinent to future research when creating or assessing usability of 





Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score chart, 




Comparison of the distribution of predictors (including missing data) for development and validation 
datasets   




AND DISCUSSION  
Interpretation of presented models (confirmatory, i.e., model useful for practice versus exploratory, 
i.e., more research needed) 
1. moderate predictive ability (AUROC 0.52–0.94) in 14 externally validated delirium prediction models 









Comparison with other studies, discussion of generalizability, strengths and limitations. 
 
Limitations: Study design, application and reporting of statistical methods appear inadequate, low 
EPV result in overfitting and over optimism of the tools and increase risk of bias.   
Variable definitions too broad: functional and cog abilities- overlap data.   
And last the outcome variable, delirium, was largely non-systematic frequency of measurement ranged 
based on time of day and was avoided weekends- delirium is fluctuating and requires increased 
screening.   
 
Generalizability: each model tends to focus on a specific population and is difficult to generalize to all 
populations, some studies are also focused on prevalent vs incident delirium 
 
Strengths: interprofessional team, multiple perspectives for recommendations for future studies.  
Systematic review that was prospectively developed.  Comprehensive literature search was completed.   
This is the first to identify study and model design issues and discusses the paucity of measurements 
sensitive to the spectrum of cognitive impairment. 
 
Implications for future research:  
1. Model aggregation 
2. Develop and broad validation simplifying cognitive tests that would include MCI and be 
sensitive to cognition 
3. Develop dynamic models using Bayesian Networks, artificial intelligence, machine learning 
4. Build predictors based on only data available prior to delirium onset 
5. Twice daily assessments of delirium-screen 
6. Include variables that are commonly available in clinical practice 
7. Follow rigorous methods outlined by Steyerberg and Vergouwe that allow for strategies to 
counter low EPV, use of Akaike info criterion and Bayesian information criterion to assess 
model fit.   
8. Broad Validation 
9. Adhere to TRIPOD for reporting methods.   









Domain Key items 
page # 
SOURCE OF DATA 
“PREDICTING 




Newman et al., 2015 
 
 
Source of data (e.g., cohort, case-control, randomized trial participants, or registry data): 
 
PubMed MEDLINE (1940-present), EMBASE (1947- present), PsychINFO (1800-present), 
CINAHL (1981-present), and Cochrane since inception.  NO date or language exclusions for 
studies through December 5 2013. Grey literature search also completed on studies found. 
PRISMA flow diagram included on pg. 409 
 
AIM: review studies of validated risk stratification models and discuss barriers to use and 







Participant eligibility and recruitment method (e.g., consecutive participants, location, number 
of centers, setting, inclusion and exclusion criteria) 
Inclusion: Original research, adult population, acute medical inpatients and presence of 




Participant description- participants here are studies of development and validation of risk 
prediction models for delirium in the hospital setting  
Inclusion: 10 studies were included, and quality assessed by a modified version of the  
Newcastle Ottawa Scale for cohort studies, noting that due to nature of the research papers 







Details of treatments received, if relevant-NA 
 
 
Study date  retrospective literature review, inception to Dec. 5th 2013   408 
OUTCOME(S) TO BE 
PREDICTED 
Definition and method for measurement of outcome 
Outcomes in this study were:  Variables Extracted: each studies variables, risk-stratification 
model- linear vs otherwise, All models tested on a validation cohort, population, delirium 
outcome assessment tool, risk factors included in prediction model, model structure, statistics 













Was the same outcome definition (and method for measurement) used in all patients? 
Outcome tool was listed and compared for each assessment model 
The outcome of this systematic review is for research in the future and identify barriers for 







Type of outcome (e.g., single or combined endpoints) 
Review and compare models, find barriers 
 
408 
Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)? 
No mention of blinding 
 
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)?  No, the 
candidate predictors were not part of the outcome of this review, this review focused on content 
of each study, though they were discussed and compared in a table form.   
 
410 
Time of outcome occurrence or summary of duration of follow-up 
No follow up needed in this study as they were evaluating studies for recommendations for 






(OR INDEX TESTS) 
Number and type of predictors (e.g., demographics, patient history, physical examination, 
additional testing, disease  characteristics) 
4. Each predictor was discussed and noted to be included in how many of the studies included out 
of 10.  Age, Illness severity, Cognitive impairment, BUN, ADL impairment, Model performance 
(validation cohorts less AUC than development), AUCs were compared, Carrasco tested +LR 
and -LR.  Use in clinical practice was also a topic-noting no model was found to be actively 





Definition and method for measurement of candidate predictors 




Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment 
initiation) 
8/10 used clinical data available at time of admission to predict subsequent delirium 
 
 
410    
Were predictors assessed blinded for outcome, and for each other (if relevant)? NA-Not relevant NA 
Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or 







Number of participants and number of outcomes/events 
10 models included. AUC/C-statistic/LRs compared.  This study did not reveal rates of delirium 
in each study or % of positive prediction  
 
410 
Number of outcomes/events in relation to the number of candidate predictors (Events Per 
Variable)   This study did not discuss EPV which would be a significant finding as EPV is 




Number of participants with any missing value (include predictors and outcomes) 
Each study reported their own missing data; however, this study did not comment on this which 





Number of participants with missing data for each predictor-NA NA 
Handling of missing data (e.g., complete-case analysis, imputation, or other methods)-NA NA 
MODEL DEVELOPMENT
  
Modeling method (e.g., logistic, survival, neural network, or machine learning techniques)  
Model design and population, delirium assessment, risk factors all compared.  The specific 
model development methods were not discussed in this review.   
 
 
Modelling assumptions satisfied-N/A  
Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate 
predictors, pre-selection based on unadjusted association with the outcome) 
This review does not create a model it simply recommends inclusions for future research 





Method for selection of predictors during multivariable modeling (e.g., full model approach, 
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion) 
This was not discussed 
NA 
Shrinkage of predictor weights or regression coefficients (e.g., no shrinkage, uniform shrinkage, 







Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test)  
Discrimination  (C-statistic, D-statistic, log-rank, AUROC) measures with confidence intervals 




Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification 
improvement) and whether a-priori cut points were used 
These were not mentioned in this study, which is a significant limitation to this study if they are 
looking for clinical limitations 
 
MODEL EVALUATION  
Method used for testing model performance: development dataset only (random split of data, 
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation 
(e.g. temporal, geographical, different setting, different investigators) 
Discussed in context of combined models- model performance evaluated by AUC or LRs.   
Clinical utility statistics such as sensitivity, specificity, positive predictive values, negative 




In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated, 
predictor effects adjusted, or new predictors added) 





Final and other  multivariable models (e.g., basic, extended, simplified) presented, including 
predictor weights or regression coefficients, intercept, baseline survival, model performance 
measures (with standard errors or confidence intervals) 
This was also not discussed but pertinent to future research when creating or assessing 
usability of these prediction models.   
Reasons for lack of implementation is cited as: complex or time consuming, variables difficult 
to measure on admission like the APACHE II, additional cognitive tests if not done right may 
incorrectly diagnose. Intensive staff education would be needed to implement, compliance 





Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score 








Comparison of the distribution of predictors (including missing data) for development and 





Interpretation of presented models (confirmatory, i.e., model useful for practice versus 
exploratory, i.e., more research needed) 
2. moderate predictive ability (AUROC 0.52–0.94) in 14 externally validated delirium prediction 




Comparison with other studies, discussion of generalizability, strengths and limitations. 
 
Limitations: possible to miss some relevant studies. Studies may have been incorrectly screened 
out; this is a qualitative review thus no attempt to pool data from the studies.     
 
Strengths: First study of its kind, comparing quality and defining reasons for lack of 
implementation in clinical practice.  Notes future focuses for research.   
They noted the heterogeneity of results and methods used to develop the models and use of risk 
factors.   
 
Implications for future research: Replicate results of current studies and compare them, 
develop new prediction tools focusing on fast reliable assessments with well-supported risk 
factors.   
Future hope: Lower cost of care and decreased mortality  may be a result of timely 















Domain Key items 
page # 
SOURCE OF DATA: 
“Models for Predicting 
Incident Delirium in 
Hospitalized Older Adults: A 
Systematic Review”   
Kalimisetty et al., 2017 
 
Source of data (e.g., cohort, case-control, randomized trial participants, or registry data): 
 
Medical librarian customized and conducted a search for all published medical articles on 
delirium prediction models.  Ovid MEDLINE, CINAHL, Cochran Database of systematic 
Reviews, EMBASE, and PsycINFO were searched using PICO- based inquiry.  Terms used 
were variants of delirium, AMS, Acute confusional stated Acute brain syndrome, acute brain 
failure metabolic encephalopathy, predict, predictive, models, modeling, scores, tests testing, 
scoring, rules, index, and indices.   Grey literature review was also completed.   
 
AIM: Summarize risk prediction models and identify the most prevalent factors of incident 
delirium in the older in-patient populations (65 or greater), for future build of a risk prediction 







Participant eligibility and recruitment method (e.g., consecutive participants, location, number 
of centers, setting, inclusion and exclusion criteria) 
Inclusion: PRISMA Guidelines used.  English language only, older population, original 
research to development models with derivation and validation cohorts. excluded systematic 




Participant description- participants here are studies of development and validation of risk 
prediction models for delirium in the hospital setting  
Inclusion: 12 studies were included, and quality assessed by a modified version of the  





Details of treatments received, if relevant-NA 
 
 
Study date  Dates not noted, nor noted in inclusion criteria    
OUTCOME(S) TO BE 
PREDICTED 
Definition and method for measurement of outcome 
Variables Extracted: study description, population, delirium assessment method, incidence of 













Was the same outcome definition (and method for measurement) used in all patients? 
Quality was defined as the NOS scale.   





Type of outcome (e.g., single or combined endpoints) 
Single endpoints, all compared in tables.   
 
70-4 
Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)? 
No mention of blinding-NA 
 
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)?  Yes, this 
study was assessing what predictors commonly are used in the RPMs.  Comparative table on 
page 74 – 75 listing all the co-efficient and statistics of each predictor.   
 
74 
Time of outcome occurrence or summary of duration of follow-up 
No follow up needed in this study as they were evaluating studies for recommendations for 






(OR INDEX TESTS) 
Number and type of predictors (e.g., demographics, patient history, physical examination, 
additional testing, disease  characteristics) 
5. All candidate predictors were compared that were found in the studies (20) 
 
74 
Definition and method for measurement of candidate predictors 
Outcomes measures:  RR, OR, B, HR (hazard ratio), SE (standard errors) 
Noting the most common risk factors used dementia, decreased functional status, high blood 




Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment 
initiation)  Any time during admission 
 
71 
   
Were predictors assessed blinded for outcome, and for each other (if relevant)? NA-Not relevant NA 
Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or 
categorized)  Uncertain as the models and stratification levels were not a focus in this review 
NA 
SAMPLE SIZE 
Number of participants and number of outcomes/events 
12 models compared for predictors.  Aim was also to summarize models, the only summary 
done was comparing retro vs prospective and the predictors 
70 
Number of outcomes/events in relation to the number of candidate predictors (Events Per 








Number of participants with any missing value (include predictors and outcomes) 
Not addressed 
NA 
Number of participants with missing data for each predictor-NA NA 
Handling of missing data (e.g., complete-case analysis, imputation, or other methods)-NA NA 
MODEL DEVELOPMENT
  
Modeling method (e.g., logistic, survival, neural network, or machine learning techniques)  
Model design and population, delirium assessment, risk factors all compared.  The specific 
model development methods were not discussed in this review.   
NA 
Modelling assumptions satisfied- N/A NA 
Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate 
predictors, pre-selection based on unadjusted association with the outcome) 
This review does not create a model it simply reviews predictors used in RPM for a future build 
of an RPM for use with HELP interventions 





Method for selection of predictors during multivariable modeling (e.g., full model approach, 
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion) 
This was not discussed 
NA 
Shrinkage of predictor weights or regression coefficients (e.g., no shrinkage, uniform shrinkage, 
penalized estimation)  N/A 
NA 
MODEL PERFORMANCE 
Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test)  
Discrimination  (C-statistic, D-statistic, log-rank, AUROC) measures with confidence intervals 




Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification 
improvement) and whether a-priori cut points were used 
These were not mentioned in this study, as they were looking for predictors and to summarize 







MODEL EVALUATION  
Method used for testing model performance: development dataset only (random split of data, 
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation 
(e.g. temporal, geographical, different setting, different investigators) 




In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated, 
predictor effects adjusted, or new predictors added) 




Final and other  multivariable models (e.g., basic, extended, simplified) presented, including 
predictor weights or regression coefficients, intercept, baseline survival, model performance 





Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score 




Comparison of the distribution of predictors (including missing data) for development and 
validation datasets  Missing data not discussed, comparison of predictors was the aim of this 




Interpretation of presented models (confirmatory, i.e., model useful for practice versus 
exploratory, i.e., more research needed) 
Very little data summarized for these RPM, the aim was to summarize them however the only 
summary given was a comparison of how many studies were prospective vs retrospective, rates 
of delirium, number of risk factors included in each was 2-6, and the most/least common risk 










Comparison with other studies, discussion of generalizability, strengths and limitations. 
 
Limitations: variation in the studies in the way they assessed for delirium.  Decreased NOS due 
to studies did not include follow up data.  Varied incidence of delirium between retrospective 
and prospective cohorts (common finding to be less rated as delirious in a retrospective study).     
 
Strengths: consistent with previous research on predictors-high number of predictors compared 
to study numbers (delirium is multifactorial in nature). 
 
Implications for future research: application of these predictive variables to a future tool for 
implementation with HELP interventions, making an automated tool to be used in the EMR.  
 
Future hope: The authors noted that they have already implemented a tool to mark pt. as at risk 
for delirium based on the Acute Care for Elders Tracker (ACE).  However, the risk factors for 
HELP may not be the best sued in the HER due to missing data.  Use of the HER with simplified 

















Statistical Comparison of the Validated Delirium Risk Prediction Models   
 






















Observed delirium cases, by 
risk level 
Discrimination 























1 point each 
 
















Writer conclusions made:  
44.4% with a score of ≥1 or 
high risk, developed delirium 
and only 7% of those low risk 
developed delirium 
Limiting interventions to 53% 
of this population, making 











































Observed delirium cases, by 
risk level 
Discrimination 



























1 point each 














10%  (5/49) 
21% (6/28) 
0%  (0/4) 
 
Writer Conclusions made:  
78% of those dx with delirium 
were correctly categorized as 
elevated risk, thus 21% of those 
with delirium would have been 
missed and not included in the 
intervention group.   
Interventions would be limited 
to 81 out of 165 or 49% of the 
total population making risk 
stratification possible.  
Including all the factors 1 or 
more would include 99% of all 
delirious but increase the 
number treated to 140, which is 
nearly 85% of the population 





































Observed delirium cases, by 
risk level 
Discrimination 














































Writer Conclusions:  this is an 
algorithm, thus those in 
moderate to high risk would be 
those you would focus 
interventions on.  1170 pts 
included; 51 cases identified.  If 
scoring included factors 3-5 
only  approx. 3% of cases would 
be missed.  (factors 0-2).  Of 
note zero patients with a zero 
score were delirious and the 
highest % delirious were 








































Observed delirium cases, by 
risk level 
Discrimination 































Age≥65  2 
Age>80  3 
Fracture   4 
Vision   1 
Severe 
illness 2 



















If you increase this to include 
positive mRASS would increase 
# to treat to 108 with 40.7% 
delirium positive and TMYB # 
to treat is 127 with 39.4% 
delirium positive.   
But if you drop the rate to 
include a score of ≥3 you 
capture 33 delirious out of 129 
or 25.5% delirious rate and 
treating 129/246 or 52.4% of the 
total of people.  Which is still 
allowing for triaging and 
allocation limitations but is 
decreasing those at risk that are 
missed.   
 
I recommend dropping the score 










































Observed delirium cases, by 
risk level 
Discrimination 
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∑Functional 
dependence 
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Se, Sp, ppv, npv 
.95, .34, .19, .98 
.52, .80, .31, .91 
.14, .96, .38, .87 
(unreported) 
Se, Sp, ppv, npv 
.95, .36, .19, .98 
.81, .68, .29, .96 
.38, .88, .35, .90 
 
Se, Sp, ppv, npv 
1.0, .34, .20, 1.0 
.95, .43, .21, .98 
.90, .55, .25, .97 
.81, .71, .31, .96 
.57, .77, .29, .92 
.48, .95, .59, .92 
.33, .93, .44, .90 
 
Se, Sp, ppv, npv 
.95, .18, .16, .96 
.95, .66, .27, .94 
.76, .66, .27, .94 
.27, .93, .70, .68 
 
Writer conclusion:  
lower  NPV and higher Sp than 
it is to have a high PPV or low 
Se because including  more 
patients in risk levels that MAY 
develop delirium is imperative 



































Observed delirium cases, by 
risk level 
Discrimination 





















AGE ≥80    2 
≈Cognitive 
Impairment2  
SIRS ≥2     1 




















Se, Sp, ppv, npv 
1,   .17,   .16,    1 
.95, .19, .16, .96 
.86, .49, .21, .95 
.81, .61, .25, .95 
.71, .88, .50,  .95 
.29, .95, 0.5, .89 
  0,    1, 1,   .86 
 
Writer conclusion: this is a well-
researched study with a very high 
AUC.  The risk stratification 
levels correlate well with the 
actual diagnosed cases of 
delirium.  Well researched risk 
factors contribute to the high 
accuracy of this test. This was a 
second study based on the same 
population as of their update 
model study 2016a. This model 
out preforms the others, as they 
learned much from the previous 






































Observed delirium cases, by 
risk level 
Discrimination 































ratio)- 4 X 
Barthel 
Index) 






















So, 99% of those that test 
negative do not develop 
delirium, thus including more of 
those at truly high risk.  Here 

















































Observed delirium cases, by 
risk level 
Discrimination 

































for each e 
learning 










































models.   
Writer conclusion:  easy to 
adjust the Se and Sp to your 
desired levels for these machine 
learning tools.   
Higher Sp and lower NPV 
would be the goal in order to 
balance interventions with less 
misses of those that do develop 
delirium.  This method would 
also be flexible enough to 
continue to modify these values 
based on data obtained during 
say a QI project or external 





as it is not 
directly stated 
the number of 




1 Note.  ∆£≠œ Type of study: ∆ Development and validation on same cohort, £ Development and validation using a different cohort, ≠ Validation only, Œ Model 
update with validation  
• Age ≥85        † DADLs: dependence in five or more activities of daily living 
* Drugs prescribed prior to admission, one point for antidepressants, antidementia, and anticonvulsants and  two points for antipsychotics 
¡ Ability to spell WORLD backwards     ∑ researchers assess patient in six activities of daily living 
Ω replaced  by dx of dementia or cognitive score cut-off point    ≈ MMSE 
 
 
 
